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The size of engineered tissues is currently limited by oxygen diffusion.  
Vascularization of these constructs could alleviate this problem if the cues 
that control blood vessel organization can be manipulated.  Our laboratory 
has adapted a method for generating bona fide capillaries in fibrin gels to 
study how mechanical strain affects the growth and organization of 
engineered blood vessel networks and remodeling of the extracellular 
matrix.  A PDMS multi-well platform was designed to allow cell culture in a 
mechanically labile environment that also allowed visualization of the 
extracellular matrix under strain.  The platform was calibrated using a 
custom microscope stage mount composed of two clamps attached to a 
micrometer for strain application.  Strains from 0 – 12% were applied to 
fibrin hydrogels and the corresponding principle strains were calculated, 
revealing a linear relationship between the two.  Cell culture experiments 
were performed using a custom, automated linear stage able to apply cyclic 
or static strains to the PDMS platform under standard mammalian cell 
culture conditions.  These experiments revealed that human umbilical vein 
endothelial cells, in the presence of supportive human aortic smooth 
muscle cells, formed vasculature parallel to the applied strain and that the 
alignment was reversible upon halting the strain.  Examination of the fibrin 
matrix revealed no cell-mediated directional matrix remodeling and only 
modest alignment of the matrix at 10% strain, the maximum used in these 
studies.  Contact guidance was thus ruled out as a primary source of 
capillary alignment, prompting an investigation of intracellular 
mechanotransduction as a mediator of the directional sprouting.  The use 
of multiple genetic constructs to modulate RhoA activity and the application 
of drugs to inhibit Rho-associated kinase, myosin light chain kinase, and 
myosin ATPase showed that perturbation of this mechanosensitive 
pathway led to decreased capillary network lengths without diminishing the 
ability of the capillaries to align parallel to the direction of applied strain.  
These findings demonstrate that mechanical inputs can be used to control 
angiogenic patterning in engineered tissues and suggest that an alternative 
mechanosensitive pathway may be responsible for directional angiogenesis 








1.1 Tissue Engineering 
 Organ and vascular malfunction play roles in six of the ten leading 
causes of death in the United States [1], contributing to over one million 
deaths in 2011 alone, and driving the need for organ transplantation.  In the 
United Kingdom [2] and the United States [3], the number of patients 
waiting for most organs vastly exceeds the number of available donors 
(Figure 1-1).  The field of tissue engineering aims to change that.  By 
building functional replacement organs and substitute tissues in the 
laboratory, tissue engineers hope to improve the length and quality of life 
for millions of people.  Although crude methods of tissue engineering have 
existed for hundreds or thousands of years, modern tissue engineering is 
attempting to truly recapitulate, and repair, living organs.  To fully realize its 





Figure 1-1 The number of people waiting for transplants exceeds the number of available organs.[2]  
organization, strength, biological functionality, and vascularization. 
 Modern tissue engineering began in the late 1980s and early 1990s 
[4-6] and has already generated several therapies and products.  
Epidermal replacements using cultured keratinocytes and fibroblasts [7], 
tissue-engineered bladders using autologous cells seeded onto collagen or 
collagen-polyglycolic acid scaffolds [8], and an engineered arterial graft 
generated using autologous tissues [9, 10] are examples of how far the 
field has come in such a short time.  These successes also highlight two 
important challenges in tissue engineering.  First, the arterial grafts 




pulsatile strain to strengthen the tissue.  While this is relatively 
straightforward in a thin, tubular construct, it remains difficult to create 
thicker tissues with the necessary mechanical properties to withstand 
implantation and normal activity.  Optimization of the conditioning phase 
with various mechanical inputs such as shear flow and cyclic strain will 
likely yield improvements to the mechanical properties of engineered 
tissues in the near future.  Second, clinically successful engineered tissues, 
such as skin and cartilage, are thin or relatively avascular.  In the case of 
successful bladder engineering, the hollow, thin tissue was in several cases 
wrapped in a vascularized omentum, facilitating nutrient exchange [8].  Thin 
tissues are better capable of functioning without a vascular supply of their 
own and rely on diffusion to provide oxygen and remove waste.  The 
maximum thickness of a tissue without its own vasculature has been 
estimated to be 100-200 m [11-13], and unsurprisingly, attempts to 
engineer tissues larger than this have met with less success. 
 
1.2 Angiogenesis and Vascularization of Engineered Tissues 
 There are two forms of angiogenesis: intussusceptive and sprouting.  
Intussusceptive angiogenesis is the splitting of an existing vessel into two 




between the two new capillaries, eventually splitting into a true capillary 
branch-point [14].  This form of angiogenesis has only recently begun to 
receive attention, and it is currently believed that its most important role is 
in vascular remodeling [15].  Vascular expansion is believed to be primarily 
driven by sprouting angiogenesis.  Upon induction by pro-angiogenic cues, 
quiescent endothelial cells making up the capillary walls begin to degrade 
the underlying basement membrane and release their cell-cell contacts.  
Relying in part on Notch-Dll4 signaling to segregate into so-called “tip” and 
“stalk” cells [16, 17], the now active endothelial cells begin to form a new 
sprout.  Tip cells lead the newly forming capillary up growth factor gradients 
[18], finally anastomosing, or joining, with another capillary to complete the 
vascular circuit [19, 20].  Stalk cells migrate behind the tip cell and form the 
body of the capillary.  These cells proliferate to allow lengthening of the 
growing sprout and will also form the lumen by fusion of intracellular 
vesicles [21].   
 Healthy angiogenesis only appears in adults under limited 
circumstances: wound healing, menstruation, and mammary gland 
development during pregnancy [22]; pathological angiogenesis manifests in 
diseases such as macular degeneration, where aberrant blood vessel 




blood supply is usurped to feed growing tumors.  This work is primarily 
about understanding angiogenesis in the context of engineered tissues.  
Discussions of pathological angiogenesis are reviewed extensively 
elsewhere [22, 23]. 
 Strategies to create vascularized engineered tissues rely on isolated 
endothelial cells self-assembling into capillary-like structures, a 
phenomenon first described in vitro by Folkman and Haudenschild in 1980 
[24].  Prior to this, methods of studying angiogenesis were limited to in vivo 
models that are much less amenable to manipulation than in vitro systems.  
Folkman and Haudenschild’s advance was quickly adapted to study 
angiogenesis in 3D protein hydrogels [25], enabling the study of the effects 
of particular growth factors on angiogenesis [26, 27].  As the field of tissue 
engineering emerged in the early 1990s the need for implantable 
vascularized tissues became clear.  Proof-of-concept for the implantation of 
such tissues was achieved when it was shown that endothelial cells 
encapsulated in collagen-fibronectin gels could be implanted into mice and 
form a network that carried blood after anastomosis with the host’s 
circulation [28].  Vascularized tissues are now routinely created for in vitro 
and in vivo angiogenesis assays [29].  Although multiple clinical trials have 




commercial products.  However, many in vitro angiogenesis models have 
been developed to improve understanding of how vascular networks are 
formed [30] and under what conditions they are most functional [31, 32].   
 One of the most important issues confounding the production of 
implantable, vascularized tissues is that they inosculate with the host 
vasculature slowly.  Therapies involving the injection of living cells, even if 
they are contained within a scaffold, will inevitably suffer from considerable 
cell death due to the lack of immediate perfusion of the tissue.  Pre-
vascularization of implantable tissue scaffolds appears to be one means by 
which this problem can be ameliorated.  Such tissues inosculate with the 
host blood supply, as evidenced by the presence of erythrocytes, much 
earlier than non-pre-vascularized tissues [33, 34].  However, because the 
process generally takes days rather than hours to complete, there is a risk 
of ischemic loss of delivered cells in the interior of the implant even in this 
case.  One potential mechanism to improve the rate of inosculation is to 
create a highly organized vascular bed, rather than randomly-oriented 
vessels.  This may allow an implant to be oriented in such a way as to 
maximize the rate of inosculation and spare the lives of implanted cells, or 
allow the creation of a larger vascular tree connected to larger vessels that 





1.3 Control of Vascular Patterning via Mechanotransduction 
 Tissue architecture is often extremely intricate, containing multiple 
cell types closely juxtaposed in complex arrangements, and the supporting 
vascular bed must ensure all cells within are in close proximity to the blood 
supply.  Therefore, understanding how the growing vasculature forms 
patterns that allow it to follow tissue architecture are critical to tissue 
engineering.  How endothelial cells organize into the highly ordered 
arrangement of capillaries that saturate most tissues remains an open 
question.  The field of tissue engineering poses another unique challenge: 
to generate an engineered tissue, cells are removed from their 
developmental context and placed in an extracellular matrix (ECM) scaffold 
that imperfectly replicates the in vivo environment, then asked to assemble 
into a functional vascular network and recapitulate a particular architecture.  
Although this strategy works surprisingly well for creating vascularized 
implants, researchers can currently assert almost no control over the 
orientation of the vessels within them. 
 One cue emerging as an important regulator of pattern 
morphogenesis is mechanotransduction via cell-cell and cell-ECM contacts.  




been hypothesized that mechanical cues are critical determinants of cell 
fate during this process [35-37].   However, the issue remains unsettled 
due to the difficulty of measuring mechanical forces under developmental 
conditions.  Outside of development it is clear that cells are influenced by a 
variety of mechanical stimuli including the rigidity of their substrate [38, 39], 
tension generated by neighboring cells [40], shear stresses from flow [41], 
and tensile stresses propagated through the ECM [42].  All of these factors 
must be understood to engineer functional tissues, but tensile stresses are 
particularly important because they represent a simple way by which 
engineers can stimulate cells within tissue constructs to simulate their 
native environment and to induce favorable morphogenetic processes.  In 
the body, endothelial and smooth muscle cells constantly experience stress 
and strain: a basal level of stress from the blood pressure itself, and cyclic 
strain from the heartbeat.  Even capillaries, shielded from the high 
pressures in larger vessels, experience stresses and strains during wound 
healing and muscle contraction during exercise.  Improved understanding 
of the mechanical microenvironment may elucidate methods that allow 
better control over the architecture of the vascular tree in engineered 
tissues. 




types relevant to angiogenesis have been studied extensively in 2D.  
Application of cyclic strain has been found to regulate pro-angiogenic 
growth factor expression in cardiomyocytes [43] and smooth muscle cells 
[44], indicating that mechanical forces may play a role in recruiting nascent 
vasculature to the wound site.  Smooth muscle cells, which help to regulate 
vascular tone, show marked changes in cytoskeletal architecture and 
decreased membrane localization of the small GTPases RhoA and Rac 
when exposed to static strain [45].  Endothelial cells are also directly 
affected by cyclic strain, up-regulating expression of the pro-angiogenic 
factors vascular endothelial growth factor (VEGF) and transforming growth 
factor-beta (TGF-β) [46].   2D studies, however, fail in some cases to fully 
recapitulate the native environment in which angiogenesis takes place.  
Gene expression, behavior, and morphology are often quite different when 
cells are cultured in 3D hydrogels rather than in a 2D monolayer and it is 
widely believed that the transition from 2D to 3D cell culture will greatly 
improve our understanding of many biological processes [47]. 
 Our lab has developed a system capable of inducing co-cultured 
endothelial and smooth muscle cells to form a complex capillary network in 
a 3D hydrogel environment, closely mimicking angiogenesis.  It is also 




levels of static or cyclic strain to the ECM.  It is known that mechanical 
forces are important regulators of angiogenesis and that endothelial cells 
will respond to contact guidance dues from the ECM: capillaries sprouting 
from dissociated microvessels embedded in a collagen matrix will align 
themselves parallel to the fibers within that matrix [48].  However, it in 
fibrin-based systems the ECM alignment due to strain is less significant, 
and it is unknown how, or if, cells will respond to mechanical strain in such 
a matrix.  Improved understanding of the cues that affect directional 
capillary sprouting will be beneficial for engineering intricately patterned 
replacement tissues that accurately mimic those found in the body.  
 Two key molecular players in cellular mechanosensing are the small 
GTPase RhoA and its downstream target Rho-kinase (ROCK).  These 
promote the assembly of actin filaments, are involved in control of cell 
motility, and promote increased cell traction force generation [38].  Rho 
kinases have also been implicated in directional migration in 2D and 3D 
environments [49], highlighting their potential importance for patterning in 
tissue engineering applications.  In addition to cytoskeletal remodeling, 
RhoA also affects pericellular remodeling of the ECM.  The structure of 
fibronectin fibers deposited by endothelial cells relies on actomyosin 




varying thickness are created when RhoA activity is modulated [50, 51], 
presumably due to its effects on traction force generation.  With such an 
intimate connection between cell traction force and the ECM, it is likely that 
applied strains will have profound effects on complex morphogenetic 
processes like angiogenesis.   
 
1.4 Hypothesis 
 We hypothesize that cyclic mechanical strain will alter the extent 
to which angiogenesis occurs and cause vascular network alignment 
mediated by a RhoA-dependent mechanism. 
 This hypothesis will be tested using a three-dimensional cell culture 
model of angiogenesis that was originally developed by Nehls and 
Drenckhahn [52], and adapted by previous researchers in our laboratory 
[53-55] to study how physical changes in the ECM influence cell function. 
 
1.5 Specific Aims 
 Specific Aim 1:  Build and characterize a bioreactor to apply 
cyclic strain to hydrogels.  Characterization will verify the relationship 





 Specific Aim 2: Study the effects of strain on angiogenesis using 
the system developed in Aim 1.  Alignment of vessels (relative to the 
direction of applied strain), the length of the resultant vascular network, and 
changes to the ECM will be quantified.   
 
 Specific Aim 3: Understand how the interplay between cellular 
traction force and cyclic strain affects angiogenesis, paying specific 
attention to a RhoA-dependent pathway. 
 
1.6 Translational Potential 
 Understanding the mechanical cues and culture conditions necessary 
for successfully patterning vasculature is a key step in advancing the field 
of tissue engineering.  One future in vivo application of this line of research 
includes the possibility to create an implantable graft with pre-patterned 
vasculature, which would allow researchers to study various configurations 
of capillary networks in vivo and parse out the patterns which best allow for 
integration with host vasculature and promote cell survival in implanted 
tissues.  It will also allow researchers to create grafts that are perfused in a 
predictable way rather than through purely random growth, as in the case 




mechanical environment around the implantation site is known, more 
accurate predictions of how vasculature will form can be made if it is known 
how mechanical forces affect vasculature in vitro. 
 Vascular tissues are not alone in experiencing, responding to, or 
creating mechanical stresses and strains, nor are they unique in their 
branched architecture.  Vascular, nerve, and lymphatic tissues all undergo 
branching morphogenesis to generate intricate patterns in development, 
and share some common responses to soluble cues, most notably VEGF 
[56-58].  Epithelial tissues such as lung and gut are also known for their 
highly branched morphology.  They may additionally share common 
responses to applied strains and thus protocols used to pattern one tissue 
may be generally applicable to others.  For example, rearrangement of the 
cytoskeleton is necessary for cell migration and proliferation, key processes 
in many cell types.  This study will shed light on how mechanical stretch 
affects RhoA and its downstream processes, potentially shedding light on 
RhoA-dependent mechanisms in other cell types. 
 
1.7 Overview 
 This dissertation is organized as follows.  Chapter 2 is a review of the 




emphasis on fibrin, is discussed with respect to its roles in normal tissue 
and during angiogenesis.  Strategies for modifying fibrin, taking advantage 
of its pro-angiogenic qualities, and its unique mechanics are discussed.  
Chapter 3 describes the invention and characterization of a bioreactor used 
to apply mechanical strains to 3D hydrogels.  Chapter 4 outlines the use of 
this bioreactor to apply strain to a 3D model of angiogenesis that permits 
the creation of vessels containing patent lumens.  Characterization of the 
length and orientation of the resultant vascular networks is presented and 
an analysis of the extracellular matrix under static and strained conditions 
is shown.  Chapter 5 examines a possible mechanism behind the effects 
observed in chapter 4, looking specifically at RhoA- and myosin-dependent 
pathways.  Chapter 6 provides a summary of the key findings and presents 
possible future directions for understanding the role of 
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 Fibrin is a natural biomaterial and the primary extracellular constituent 
of blood clots, halting the flow of the blood from open wounds.  Given 
fibrin’s role in the earliest stages of wound healing, it is not a surprise that it 
has been explored for use in regenerative therapies.  Fibrin’s structure and 
bioactive properties encourage sprouting of new blood vessels 
(angiogenesis) into the wound, and cells readily degrade it during healing.  
Biodegradable matrices such as fibrin are ideal for tissue engineering 
applications because they potentially allow for complete tissue 
regeneration, leaving no trace of the original scaffolding material.  Although 
fibrin can support many complex morphogenetic processes, this review will 
highlight its strength as a material capable of supporting angiogenesis.  




as a biomaterial, fibrin’s permissiveness of vascular morphogenesis makes 
it useful for studying the engineering principles governing cellular behavior 
in native three-dimensional ECMs [1].  Furthermore, fibrin structure-function 
relationships are currently being exploited in two primary contexts: 
modifying native fibrin to achieve specific functionalities, and guiding 
synthetic biomaterial engineering to more closely mimic native tissue. 
 
2.2 Structure and Degradation of Native Fibrin 
 Fibrin’s complexity confers many functions, which are primarily 
dictated by the protein’s structure.  Although this acknowledgement 
appears elementary, understanding structure-function relationships of well-
characterized extracellular proteins, such as fibrin, is fundamentally 
essential to dictate the design of novel biomaterials. To act reproducibly 
and controllably, engineered biomaterials must possess similar structure-
function properties as the proteins they wish to emulate.  In a decade of 
research in our own laboratory, we’ve come to appreciate that fibrin’s 
structure is not an unnecessary clutter that can be swept away by clean 
synthetic biomaterials, but rather that it is a blueprint for superior 
biomaterial design. 




 The fibrin matrix is a web of cross-linked fibrils generated by cleavage 
of fibrinogen, a soluble plasma protein which circulates in the body at a 
concentration of approximately 3 mg/ml [2].  Fibrinogen is a hexameric 
protein containing two identical sets of three disulfide-linked peptides, 
termed the A, B, and  chains.  These peptides form a symmetric, 
extended protein composed of two flanking D-domains and a central E-
domain linked by two coiled-coil regions [3]. This dumbbell-shaped 
structure is central to the polymerization of fibrin, the insoluble protein 
formed from fibrinogen when fibrinopeptides A and B are cleaved by 
thrombin during the clotting cascade [4].  These cleavages expose the 
knob- “A” and knob- “B” regions, and their complementary binding sites, 
holes “a” and “b” [5].  Fibrinopeptides A and B, and therefore knobs “A” and 
“B,” are located in the E-domain, at the molecule’s center, while holes “a” 
and “b” are located in the D-domains.  In addition, two C regions are 
liberated upon cleavage of fibrinopeptide A.  These regions are long and 
thin with a globular head, which can interact with the heads of other C 
regions to allow for lateral aggregation of fibrils [6].  Studies of the 
knob:hole interactions support John Ferry’s 1952 hypothesis of fibrin fiber 
formation [3, 7, 8], which suggests that cleavage of the fibrinopeptides 





Figure 2-1. Schematic of fibrinogen and its assembly into fibrin. This cartoon representation shows the 
central E domain of fibrinogen flanked by the two globular D domains linked together by coiled-coil 
regions.  Thrombin cleavage of fibrinopeptides A and B from the E domain leads to dimerization of 
soluble fibrin molecules into fibrin dimers, the first step of fibrin polymerization.  Additionally, thrombin 
the growing fibrin polymer. Figure adapted from [6] with permission from John Wiley and Sons. 
binding of the D and E domains, with lateral aggregation through the C 
regions promoting aggregation into protofibrils and larger fibers [9].  This is 
illustrated in Figure 2-1, which depicts fibrinogen structure and the early 
polymerization events of fibrin.  Upon assembly, fibrin protofibrils exist in a 
twisted conformation, reflected in the full fibrin fiber, causing it to twist as 




fibers undergo ever greater stretching.  Once the energy required to stretch 
a protofibril exceeds the energy of binding, thickening of fibers ceases, 
limiting fibrin fiber diameter [10]. 
 The transglutaminase factor XIII is critical for improving the stiffness 
and stability of the fibrin matrix.  Factor XIII is carried by fibrinogen in the 
blood, bound to fibrinogen’s -domain [11], ensuring the presence of ample 
factor XIII during clotting (Fig. 2-1).  Like fibrinogen, factor XIII is cleaved by 
thrombin to generate its active form, factor XIIIa.  Factor XIIIa reinforces the 
fibrin matrix by cross-linking laterally-adjacent  chains, creating - dimers 
in protofibrils and accelerating fibrillogenesis.  These Factor XIIIa-mediated 
cross-links are believed to contribute to the extensibility of fibrin fibers [12].  
Factor XIII also creates C-C cross-links in the fibrin matrix to further 
stabilize laterally-aggregated protofibrils, increase the elastic modulus of 
the matrix, and decrease its susceptibility to proteolysis [9, 13, 14]. 
2.2.2 Fibrinolysis 
 Within the lumens of blood vessels, vascular patency is chiefly 
regulated by the plasmin/plasminogen system, which serves to dissolve 
clots and prevent fibrin from depositing in various organs.  Urokinase-type 
plasminogen activator (uPa) and tissue-type plasminogen activator (tPa) 




plasmin, the protein most responsible for fibrin proteolysis and 
maintenance of vascular patency in vivo.  Plasminogen is a soluble, 
inactive pro-peptide found in serum that also binds to the αC region of 
fibrin, at residues Aα392-610.  Plasminogen is converted to plasmin via 
cleavage of Arg561-Val562 [15] in the presence of a ternary complex in 
which plasminogen and tPa are both bound to fibrin, localizing proteolysis 
to the clot [16].  Plasmin cleaves fibrin in a series of steps resulting in 
fragments of various sizes being solubilized and freed from the clot; the 
size of the final degradation products is believed to be dependent on the 
presence of blood flow, which can carry away larger fragments [17]. 
 Additionally, cell-surface receptors for plasminogen are hypothesized 
to be of use for localizing fibrin proteolysis during various cell processes 
[18].  For example, ECs have been shown to express the cell membrane 
protein urokinase plasminogen activator receptor (uPaR), which binds uPa, 
and in certain contexts is required for tube formation [19].  However, as we 
will discuss later in this review, it is now pretty clear that an alternate 
fibrinolytic mechanism that depends on matrix metalloproteineases (MMPs) 
is responsible for EC-mediated degradation of the provisional fibrin matrix 
during sprouting angiogenesis.  




 Cells can adhere to fibrin directly via multiple motifs, and indirectly via 
interactions between fibrin and other ECM proteins.  Discussing all of the 
possible mechanisms by which cells can bind to fibrin is beyond the scope 
of this review, but we would like to highlight a few that are particularly 
important in how endothelial cells (ECs) interact with fibrin.  Perhaps the 
most significant adhesive interaction between ECs and fibrin occurs 
indirectly via fibronectin, which has the capacity to bind directly to fibrin.  
Like fibrinogen itself, fibronectin is present in blood serum, which ensures it 
is readily available to bind to fibrin during clot formation in vivo.  Multiple 
adhesive domains within fibronectin are then available for binding of ECs 
and other cells.  Furthermore, ECs [20, 21] and fibroblasts [22] can also 
both bind to Arg-Gly-Asp (RGD) sequences in fibrin using the v3 integrin 
receptor, although there is evidence that this binding mechanism is not 
required for endothelial tube formation [23].  Alternatively, the 15-42 
segment of fibrin, a heparin binding domain exposed upon cleavage of 
fibrinopeptide B [24, 25], can also play a role in EC attachment to fibrin via 
their VE-cadherin receptors [26-28], and exposure of this sequence may be 
critical for EC spreading and capillary formation in fibrin gels [23, 25]. 






2.3 Using fibrin to study angiogenesis 
2.3.1 Conventional angiogenesis assays 
 Fibrin supports robust angiogenesis in a variety of assays including 
2D and 3D environments, mono- and co-culture systems, and other 
systems capable of examining the influences of mechanical stimuli and 
microfluidic gradients.  The simplest 2D assay performed on a fibrin gel is a 
cord formation assay, where endothelial cells (ECs) are seeded atop the 
gel and induced to form cords [30].  This assay typically requires only 18-24 
hours to generate cord structures, making it a popular assay.  Although 
many molecules regulating angiogenesis have been discovered via this 
type of assay, a major weakness is that non-EC types have also been 
shown to form cords [30]. 
 By contrast, many truly 3D assays have been developed in fibrin and 
other natural hydrogels. One of the most convenient and widely-used 3D 
assays was originally developed by Nehls and Drenckhahn, who coated 
calf pulmonary artery ECs onto microcarrier beads, embedded them in a 
fibrin gel, and showed they migrate off the beads and undergo 
angiogenesis when stimulated by certain soluble factors [31].  An 





Figure 2-1. Fibrin hydrogels are useful as 3D model systems of angiogenic sprouting. High magnification 
confocal images of a sprouting capillary in a 3D fibrin matrix containing FITC-conjugated fibrinogen.  
HUVECs cultured in fibrin gels form capillaries with hollow lumens as demonstrated by confocal sections 
obtained at the bottom (left), center (middle), and top (right) z-planes of a capillary.  HUVECs were 
stained with Oregon Green 488 phalloidin and nuclei were counterstained with DAPI.  The HUVECs 
create a 3D channel in the fibrin matrix via proteolysis.  
reference point for easy quantification of vessel length and direction.  The 
microcarrier-based technique has been expanded upon to include various 
EC types, but modification of the assay was required for translation to 
human cells.  Human umbilical vein endothelial cells (HUVECs) were 
shown to form capillaries only when co-cultured with a supporting cell type.  
Human dermal and lung fibroblasts cultured atop the gel stimulated the 
formation of robust, lumen-bearing capillaries (Figure 2-2) [32, 33].  
Attenuation of angiogenesis was achieved by increasing the distance 
between the two cell types [34] and by increasing matrix density [32, 35].  
Distributing either mesenchymal stem cells (MSCs) [32] or lung fibroblasts 
[35] throughout the matrix resulted in a nearly complete rescue of capillary 
network length, demonstrating that this system can be used to study more 





 A variation of the microcarrier model uses EC spheroids, generated 
by culturing ECs in non-adherent dishes, causing them to aggregate. When 
these spheroids are placed into fibrin and collagen gels, they are capable 
of forming capillaries containing hollow lumens [36].  This assay was 
originally performed as a mono-culture but has also been adapted for co-
culture.  Microcarrier and spheroid assays have two additional advantages: 
first, ECs begin the assay very close together and thus have a large 
“reserve” of cells to from which to form extensive capillary networks; 
second, the assay is more representative of an in vivo angiogenic program 
because the cells begin as a confluent monolayer. 
 Another simpler 3D assay is more representative of vasculogenesis. 
ECs randomly distributed in a hydrogel are induced to form a de novo 
capillary network.  The advantage of this system is that the homogeneous 
cell distribution is amenable to in vivo, microfluidic, and multi-well plate 
formats. Systems with homogeneously distributed ECs have been used to 
examine integrin attachments during EC vacuolation, a result that would be 
difficult to observe in 2D culture [37].  Fibrin/collagen composite matrices 
containing a co-culture of ECs and MSCs have also been created to probe 




increasing the relative fibrin content improved vasculogenesis in these gels 
[38].  Although more difficult to quantify than microcarrier-based 
angiogenesis assays, vasculogenesis assays replicate many of the same 
features and may also be more representative of the process by which a 
bolus of cells injected within a supporting ECM in vivo form new 
vasculature. 
3.2 Microfluidic Systems 
 Studying angiogenesis, and specifically the perivascular niche, is 
simplified in microfluidic systems [39, 40]. Our laboratory has used one 
such device to image vasculogenesis in fibrin gels, and discovered that 
MSC recruitment to perivascular locations is 61 integrin-dependent [39]. 
Recently, systems with perfusable vasculature have been developed to 
improve the physiological relevance of these in vitro microfluidic assays.  In 
one study, human endothelial colony forming cell-derived ECs (ECFC-ECs) 
and normal human lung fibroblasts were co-cultured in a microfluidic device 
containing daisy-chained tissue chambers and shown to produce 
vasculature that inosculates with a perfusable flow chamber [41].  Another 
device used fibrin-filled parallel chambers that allowed invading ECs to 
form perfusable lumens spanning the length of the chamber [42]. 




 Fibrin provides a permissive matrix for angiogenesis, circumventing 
the need to engineer a new material to study cell behavior in this context.  
As a result, fibrin-based systems remain useful tools in which to study 
morphogenesis, but understanding the precise signals fibrin provides to the 
constituent cells remains an ongoing challenge.   
 There are several unanswered questions about fibrin’s ability to 
support angiogenesis.  Few studies directly compare performance between 
ECM materials, and those that do use widely differing protocols and 
materials [38, 43, 44], making it difficult to compare across studies.  
Additionally, the differences between the cues fibrin presents to constituent 
cells and the cues other ECM materials present are not well understood.  
Parsing out how the structural properties of fibrin differentiate it from other 
materials, with respect to how it presents morphogenetic cues to 
constituent cells, can guide the development of future biomaterials capable 
of more intricate control of cell behavior. 
 
2.4 Protease-mediated migration and angiogenesis in fibrin 
 The present and the future of biomaterial design lies in the concept of 
biomimicry. Generating materials that interact with living tissues in 




how cells interact with native tissues in vivo, especially in both regenerative 
and pathologic microenvironments.  The presence of fibrin-rich matrices in 
both of these microenvironments has led to investigation of cell migration 
and signaling in fibrin gels. 
 Damage to existing vessels as a consequence of wounding results in 
fibrinogen leaking from existing vessels and forming a provisional clot upon 
enzymatic cleavage by thrombin.  This clot serves as an interstitial matrix 
that must be actively remodeled by resident cells for a wounded tissue bed 
to be revascularized.  Furthermore, during sprouting angiogenesis in vivo, 
fibrinogen may leak from budding neovessels and generate a fibrin-rich 
matrix that must be negotiated by invading cells. The MMP family of zinc-
dependent endopetidases break down a variety of matrix proteins, and are 
now known to complement, and sometimes replace, the 
plasmin/plasminogen system during angiogenesis. Membrane type-1 
matrix metalloproteinase (MT1-MMP) was first implicated in angiogenesis 
when it was observed that plasmin deficiency did not inhibit 
revascularization of mouse skin wounds [45] or fibrin neovascularization 
[46], leading to the discovery that MT1-MMP is a critical, and perhaps 
required, fibrinolytic enzyme during angiogenesis [46].  Our own lab has 




where we have shown that both MMPs and plasmin can be employed for 
neovascularization in fibrin gels.  Which proteases are involved depends in 
part on the choice of supporting stromal cells used to support angiogenesis 
in our fibrin-based co-culture system [47, 48].  In addition, silencing MMP-2 
and MMP-9 exhibited no effect on angiogenesis in our co-culture model, 
implying that MT1-MMP is the most important, and possibly only, MMP 
used by endothelial cells in this system [49].   When plasmin is employed, 
MT1-MMP is still active and may play a role in regulating vessel width [48].  
This illustrates that in addition to understanding how particular cell types 
interact with the ECM in isolation, it is critical to understand how paracrine 
cross-talk affects cell-matrix interactions. 
 An evolving mechanistic understanding of these and other types of 
cell-matrix interactions continues to enhance efforts to engineer ECM 
mimetics tailored for specific microenvironments. Although fibrin can be 
degraded by multiple proteases, polyethylene glycol (PEG) based blank-
slate materials can be generated with proteolytic susceptibility that is more 
restricted in a customized manner [50, 51], facilitating mechanistic studies 
of proteolysis [52, 53]. Building on these concepts, several promising in 
vitro models of neovascularization have been created in the context of 




peptides [54-57]. These studies are particularly remarkable considering that 
these gels present a fairly minimal set of instructive cues, relative to a 
natural material like fibrin. Tethering or sequestering angiogenic growth 
factors adds an additional element of biomimicy to protease-susceptible 
synthetic hydrogels, and such systems have shown potential to enhance 
angiogenesis in vivo [56, 58, 59].  Although it cannot be said that these 
materials are directly “fibrin-inspired,” there is at least one strategy that 
claims inspiration directly from fibrin: factor XIIIa has been used to create 
hydrogels of PEG-peptide conjugates [60].  An enzymatic cross-linking 
step, which is completed under more physiological conditions than other 
chemical cross-linking strategies, represents a step toward bridging the gap 
between natural and synthetic materials.  We believe that synthetic 
materials can be further improved by mimicking additional, perhaps 
undiscovered, features present within natural hydrogels like fibrin. 
 
2.5 Studying mechanotransduction with fibrin 
 As the provisional matrix in wound healing, fibrin’s main function is to 
plug wounds and stop blood loss, resisting the blood pressure and shear 
stress to stay in place. Fibrin fibers and clots exhibit unique mechanical 




details of how are as yet incompletely known. Understanding the 
mechanical design principles behind fibrin clots is already facilitating 
strategies to engineer new biomaterials, but also led to efforts to 
understand how cells embedded within fibrin sense and respond to 
mechanical cues. 
Fibrin is one of the most extensible proteins known, exceeding even 
elastin [61].  Individual fibers can be strained to approximately 330% [62] 
and whole clots to at least 150% [63, 64], and still recover elastically.  
Fibrin also exhibits strain stiffening, like most biological matrix proteins.  
These characteristics are believed to be caused by the unique unfolding of 
the individual fibrin monomers under strain, maintaining gel integrity and 
extensibility while possessing a low volume of protein [61-64].  These 
effects are typically not present in synthetic gels. Furthermore, fibrin’s 
nonlinear elasticity enables cell-cell communication through mechanical 
means across relatively long distances.  For example, fibroblasts sparsely 
seeded on (2D) and within (3D) fibrin matrices were able to communicate 
and form patterns at distances of approximately 0.5 mm, or about 5 cell-
lengths away.  This effect was not present when linearly elastic 




 One potential mechanism by which both externally applied and cell-
generated forces can potentially alter cell responses in fibrin is via force-
induced alignment of the matrix.  However, there are discrepant views 
about fibrin’s potential for contact guidance.  Korff and Augustin reported 
that sprouts from EC-containing spheroids cultured close together grew 
toward each other in 3D collagen gels [36]. They also cultured EC 
spheroids atop collagen and fibrin gels, and observed directional migration 
only on collagen.  They concluded that alignment of the large (several 
microns long) collagen fibers was responsible for the directional migration, 
while the fibrin fibers were too short to align and thus unable to provide as 
a contact-guidance cue.  This study was a key step in the examination of 
how fibrillar structure can be exploited to guide cell growth, but the 2D 
nature of the comparison between collagen and fibrin limited its utility.  
Later work has shown that fibrin can play a role in contact guidance. 
 Recent studies in fibrin have shown the importance of mechanical 
effects such as fiber alignment and gradients in fiber stiffness for directing 
cellular alignment, migration, and angiogenesis.  Fibrin clots undergo 
pronounced fiber alignment at only 25% strain, which induces alignment of 
smooth muscle and endothelial cells cultured within the gels [66], and EC 




and by cell traction forces [67].  Fiber alignment also affects ECM 
deposition by embedded cells; however it is difficult to separate the effects 
of fiber alignment from those of matrix stress generated by cell traction 
forces [68]. 
 Cell alignment in fibrin gels also appears to be dependent on local 
anisotropies in matrix stiffness.  Using a device capable of applying small 
strains to fibrin gels, combined with laser tweezers for measuring local 
matrix stiffness, it has been demonstrated that applied strains generate 
stiffness gradients in fibrin matrices without detectable changes in fiber 
architecture. Smooth muscle cells cultured within these strained gels 
aligned perpendicular to the gradient (or parallel to the applied strain), 
showing that cells respond to gradients of matrix stiffness within natural 
biomaterials [69].  Such matrix anisotropies may also be important in 
angiogenesis.  For example, we have shown that the matrix surrounding 
growing capillaries is twice as stiff than the matrix elsewhere [70], which 
complements other results showing that branching morphogenesis occurs 
in mammary epithelium at regions of high strain [71].  Matrix anisotropies 
may thus be a general mechanism by which cells orient themselves and 
communicate with each other in 3D environments, and natural biomaterials 




quantification of stress-strain relationships is difficult in natural materials 
because they are often inhomogeneous.  This complication highlights a 
potential advantage of synthetic biomaterials in the context of better 
understanding mechanical influences on cell behavior in 3D.  However, the 
dynamic, strain-stiffening properties of natural materials provide a means 
for long range cell-cell communication, and ways to replicate this type of 
behavior in synthetic biomaterials likely need to be incorporated into 
synthetic biomaterials if they are to support robust morphogenetic 
programs. 
 The vast majority of mechanobiology studies of ECs have focused on 
their response to shear stresses induced by blood flow [72], but ECs are 
also sensitive to cyclic strain.   ECs cultured in vitro have shown increased 
expression and secretion of tPA [73, 74] and various MMPs [75] when 
strained, implying a role for cyclic strain in vascular remodeling.  Work from 
our own lab has used a modified version of the microcarrier bead assay 
described earlier to show that HUVECs will form capillaries parallel to the 
direction of applied uniaxial strain without affecting total vascular network 
length [76].  Fibrin enables these experiments because it robustly supports 
angiogenesis, but improvements in synthetic gel preparation, inspired by 




experiments as well. 
 
2.6 Clinical Applications of Fibrin 
 Unmodified fibrin has also been extensively used as a vehicle for cell 
delivery in many tissue engineering applications, and a broad review can 
be found in [1].  Notably, fibrin glues and constructs more closely 
representing physiological fibrin concentrations have been prepared, and 
cells from virtually all tissues have been implanted into animals using fibrin 
scaffolds.  Cell transplantation is much more effective when using a 
scaffold material to contain the implanted cells [77, 78], and fibrin is an 
ideal scaffold for transplantation because precursor solutions containing 
fibrinogen, thrombin, and cells can be injected in a minimally-invasive 
manner without the need for open surgery. 
 The most notable achievement of fibrin research is the use of fibrin 
glue as a surgical sealant.  Tisseel™, cleared for use by the Food and Drug 
Administration in 1998, was the first commercial fibrin sealant in the United 
States. Surgeons had earlier been using fibrin glue from noncommercial 
sources [79].  Fibrin sealants have displayed biocompatibility and 
performance in surgical hemostatic applications.  Although all naturally 




fibrin sealants have benefitted from excellent screening procedures and 
have not been linked to transmission of any viral pathogen [80].  The 
sealants are a combination of high-concentration, frozen or lyophilized 
fibrinogen and thrombin packaged in a double-barreled syringe so that the 
components mix as the sealant is dispensed [81].  These glues typically 
contain factor XIII and aprotinin to improve clot mechanics and prevent 
sealant degradation. Concentrations of fibrinogen and thrombin vary from 
60-120 mg/ml and 250-1000 IU/ml, respectively, representing 
concentrations several orders of magnitude above physiological.  These 
features decrease clotting time and improve clot rigidity [82].   
 Fibrin matrices have been used to study vascularization strategies for 
tissue engineering and treatment of ischemic disease.  The most prominent 
of these is ischemia due to myocardial infarction (MI), a leading cause of 
death in the United States.  The first attempt to treat this in mice using fibrin 
glue showed that the injection of a Tisseel™ fibrin matrix improved cardiac 
function and neovascularization in the infarct site with and without the 
inclusion of cardiomyocytes in the gel [83, 84].  Additionally, the fibrin glue 
supported cardiomyocyte survival in vitro for seven days, demonstrating 
that high concentrations of fibrin are capable of supporting cells.




vascularized, implantable fibrin tissues.  HUVECs and lung fibroblasts have 
been used to generate such tissues prior to subcutaneous implantation into 
immune-deficient mice, which led to faster inosculation with the host 
vasculature than cell-laden, non-vascularized tissues [85].  Pre-
vascularization is a promising and potentially translational strategy that may 
prove even more useful once tissue engineering has matured and 
generates large tissues and even whole organs.  However, whole tissue 
implantation is invasive and therefore not ideal when an organ may be 
saved through alternative means.  One non-invasive option is to inject a 
fibrin precursor solution containing appropriate cells to an injury site.  We 
have used subcutaneous injection of cell-laden fibrin precursor solutions to 
study how co-transplantation of HUVECs with various supporting cell types 
affects the subsequently formed vasculature. The stromal cells supported 
vasculature of varying quality, with bMSCs and adipose-derived stem cells 
(ADSCs) supporting slower vessel growth but more mature vasculature that 
displayed little leakage, possibly indicative of enhanced wound healing with 
normal vessel ingrowth.  By contrast, NHLFs supported vasculature that 
grew quickly but remained immature and leaky, characteristic of a 
pathological wound healing environment or tumor vasculature [86].  The 2.5 




supraphysiological fibrin concentrations are not required in such 
applications.  The versatility of supporting various angiogenic programs and 
co-culture systems makes fibrin an ideal matrix to study angiogenesis in 
vivo. 
  
2.7 Re-engineering fibrin for specific applications 
2.7.1 Modifying Fibrin for Controlled Growth Factor Presentation 
 Fibrin can be used as a substrate for studying cell behavior in vitro 
and as a cell-delivery vehicle in vivo, but a fundamental understanding of 
fibrin’s biochemistry has also led to the ability to augment its capabilities 
and turn it into a “smart” material.  A demonstration of this concept 
pioneered by Jeffrey Hubbell and colleagues exploits the ability of Factor 
XIIIa to incorporate bifunctional peptides into the fibrin matrix [87] for novel 
growth factor presentation and drug delivery applications (Fig. 2-3).  In one 
example, the extracellular domain of chick ephrin-B2 was attached to fibrin 
via factor XIII and was shown to increase angiogenesis over control fibrin 
gels [88] in the absence of cells.  Other factors, including -nerve growth 
factor (-NGF) and vascular endothelial growth factor (VEGF), have also 





Figure 2-1. Engineering fibrin for controlled growth factor presentation.  (A) The recombinant protein TG-
ephrin B2, the full length ectodomain of ephrin B2 fused to a transglutaminase-sensitive (TG) motif, was 
conjugated to fibrin via factor XIIIa through the TG region of the protein.  (B) Modifying fibrin in this way 
improved the angiogenic response of acellular fibrin implants in a chick chorioallantoic membrane (CAM) 
model, producing localized angiogenesis at the implant site.  Pure fibrin implants showed little vessel 
ingrowth.  (B) In vivo examination of microvascular growth on the growing CAM revealed strong and 
specific induction of new vessels by ephrin-B2 from fibrin grafts. Blood vessels were monitored by in vivo 
fluorescence microscopy performed after Intravenous injections of FITC-dextran, and showed larger 
diameters of vessels induced by ephrin-B2 indicative of arterioles or venules; by contrast, no changes of 
the regular vessel pattern of the CAM were observed in response to plain fibrin. Figure adapted from [88] 




linker that allows the factors to be released from the matrix upon enzymatic 
digestion.  Similar strategies have been used to engineer increased heparin 
affinity of fibrin by incorporating a heparin-binding domain at the biologically 
active site at a ratio of up to 8 moles of peptide per mole of fibrinogen [91].  
This approach enabled fibrin to efficiently sequester a variety of heparin-
binding growth factors, including acidic and basic fibroblast growth factors 
(aFGF, bFGF) [92], neurotrophin-3 (NT-3), and platelet-derived growth 
factor-AA (PDGF-AA) [93].   
 Additional methods of engineering fibrin for controlled release and 
protein sequestration have emerged as well.  In one example, heparin was 
directly attached to fibrin matrices via carbodiimide chemistry at a molar 
ratio of approximately 1:1, and then used to control the release of bone 
morphogenetic protein-2 for bone regenerative therapy [94]. In another 
example, fibrin knob:pocket interactions were engaged by using custom 
peptides, which were also conjugated to a fibronectin protein fragment.  
Characterization of the fibrin gels generated using this method showed 
improved mechanical properties when the “b” pocket was engaged by its 
conjugate peptide with no decrease in the angiogenic potential of the gels 




these and other examples collectively illustrate the ability to customize it in 
innovative new ways for specific purposes.  
 
2.7.2 Chemical Modification of Fibrin(ogen) 
 Despite fibrin’s versatility in a wide range of regenerative medicine 
applications, its relatively weak mechanical properties may limit its utility for 
some applications. One potential means to improve mechanical properties 
is to conjugate fibrinogen with polyethylene glycol (PEG), either with [96] or 
without [97, 98] retention of the protein’s thrombin-mediated clottability.  
PEGylation provides an approach to better control the scaffold material 
properties, maintain the biological activity of the native protein, and provide 
a mechanism for sequestering growth factors within the gel for drug 
delivery.  We have shown that PEG-fibrinogen supports cell adhesion, 
spreading, proliferation, and differentiation of some cell types in vitro [98, 
99]; however, its potential to support complex morphogenetic processes, 
such as angiogenesis, remains unrealized in our hands.  A similar 
PEGylated fibrin material has been used to deliver mesenchymal stem cells 
into the heart, validating the use of these types of gels for cell therapies in 
vivo [100].  Similarly, PEG-peptide conjugates which mimic the knob:hole 




non-covalently by disrupting native knob:hole interactions and decreasing 
the gel modulus [101]. In this strategy, the fibrin(ogen) molecule was 
unmodified, leaving its biological functionality intact.  It has further been 
shown that these types of interactions do not disrupt angiogenesis, and 
thus may lead to improved control of gel mechanics in variety of fibrin-
based biomedical applications [102-104].  
  
2.8 Conclusion 
 Fibrin is an elegant and prototypical material characterized by a long 
list of features: fibrillar architecture, considerable extensibility, strain 
stiffening, multiple adhesive domains, susceptible to multiple proteases, 
and abilities to sequester and release growth factors.  These characteristics 
enable fibrin to outperform all synthetic material platforms engineered to 
date, particularly in terms of its ability to support angiogenesis.  However, 
these impressive features also complicate the use of fibrin for fundamental 
studies as it is typically impossible to decouple fibrin’s multiple instructive 
cues in an attempt to ascertain how cells respond to any one particular 
input; thus, the use of fibrin (or any natural material for that matter) for 
fundamental works requires caution with respect to interpretation.  On one 




its function from the “top-down” continue to be well-served by an improved 
understanding of its structure-property relationships, yielding potential new 
applications without the need to engineer a new material from scratch.  On 
the other hand, an improved understanding of fibrin’s intricacies and 
complexities continue to inspire “bottom-up” designs of new material 
platforms.  Together, these two paradigms ensure that fibrin, a classic 
material with an already long history of utility, will continue to be a staple in 
the biomaterials community. 
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Chapter 3  
 
Using Cyclic Strain to Pattern Angiogenesis 
 
3.1 Introduction 
 Mechanical signals are key regulators of cell behavior [1], and serve 
as an important link to the extracellular environment.  Cells exist in a force-
balance between external mechanical inputs and internal, cell-generated 
traction forces.  This “tug-of-war” induces a state of pre-stress in the 
system, making cells exquisitely sensitive to changes in their mechanical 
environment [2]. Changes in tissue mechanics are symptomatic of many 
disease states.  For example, tumor extracellular matrices are generally 
much stiffer than surrounding tissues, and tumors often have higher 
interstitial fluid pressure, both of which alter cell behavior [3].  Increases in 
stiffness affect the vasculature within a tumor as well [4], contributing to 
vessel leakiness and metastasis.  Changes in the mechanical 




lead to changes in tissue function. 
 While such mechanical changes in the microenvironment have been 
linked with numerous pathologies [5, 6], mechanical stimulation can also be 
applied to induce desirable changes in cell behavior.  Cells not only 
respond to passive mechanical cues, such as ECM stiffness, but to forces 
that are actively applied to the matrix, providing a robust way to modify cell 
behavior.  Mechanical stimulation has been shown to improve the integrity 
of engineered vascular grafts [7, 8], demonstrating the utility of using 
mechanical signals to improve outcomes.  Despite the success of 
mechanical preconditioning in engineered tissue applications, a better 
understanding of how the ECM transduces mechanical signals to resident 
cells might enable the use of applied mechanical forces as a way to control 
tissue patterning and morphogenesis. Endothelial cell behavior is relatively 
well characterized in 2D [9] but it is less clear how strain alters their 
behavior when challenged to undergo a complex morphogenetic program 
in 3D, such as angiogenesis [10, 11]. 
 We have developed a system to study the effects of mechanical 
inputs on angiogenesis by adapting a 3D, microcarrier-based angiogenesis 
assay, first described by Nehls and Drenckhahn [12].  Human umbilical 




microcarrier beads are embedded in a fibrin matrix and co-cultured with a 
monolayer of human aortic smooth muscle cells (HASMCs) atop the gel.  
This 3D culture model is contained with a custom-designed 
polydimethylsiloxane (PDMS) multi-well platform capable of housing natural 
and synthetic hydrogels.  When clamped into a linear stage, a well-defined 
static or cyclic uniaxial strain may be applied to the PDMS, which 
propagates the strain to the ECM and the embedded cells.  We show that 
the application of cyclic strain causes sprouting parallel to the applied 
strain, and that this biasing is lost if strain is removed.  We also show that 




3.2.1 PDMS Multi-Well Plate and Stretch Device 
 A PDMS multi-well slab was designed to support 3D cell cultures and 
to enable them to be subjected to strain (Fig. 3-1 a). To fabricate the multi-
well slab, a Teflon® mold was machined to house the PDMS during curing. 
The wells within the PDMS slab are cubic, 5 mm on a side, and spaced 5 





Figure 3-1. Devices used to house and apply strain to hydrogels. (A) PDMS multi-well plate, (b) schematic 
of microscope stage insert used for calibration of micro-scale strain, and (c-e) linear stage used to apply 
cyclic strain to PDMS multi-well plate.  
edge of the PDMS to facilitate clamping. During strain experiments, the 
PDMS slab was clamped into a linear stage (Newmark Systems, Mission 
Viejo, CA) capable of providing precise, reproducible strain (Figs. 3-1 c–e).  
The clamp apparatus was covered with a lid to improve sterility and a 
reservoir to keep the semi-open culture system at 100% humidity during 
cell culture. The reservoir was filled with sterile ddH2O at the start of the 
experiment and replenished as necessary.  Once the wells of the plate 
were loaded, the system was placed into a standard cell culture incubator. 
 
3.2.2 Cell Culture 




previously described [13].  The cords were obtained via a process 
considered exempt by the University of Michigan’s institutional review 
board because the tissue is normally discarded, and no identifying 
information is provided to the researchers who receive the cords.  Cord 
veins were flushed with Dulbecco’s phosphate-buffered saline (DPBS, 
Gibco, Carlsbad, CA), then a 0.1% collagenase type 1 (Worthington, 
Lakewood, NJ) digestion was performed for 15 minutes to release the 
endothelial cells from the vessel wall.  The vessel was flushed with DPBS 
and the resulting cell suspension centrifuged, plated, and washed after 24 
hours with DPBS to remove any residual erythrocytes.  HUVECs were 
cultured in Endothelial Growth Medium-2 (EGM-2, Lonza, Walkersville, 
MD) and used at passage 3.  Primary HASMCs (Cascade Biologics, 
Portland, Oregon) were cultured in Medium 231 supplemented with Smooth 
Muscle Growth Supplement (SMGS, both Invitrogen).  HASMCs were used 
before passage 15.  All cell culture was performed in a 37°C, 5.0% CO2 
incubator.  Media was changed every other day. 
 
3.2.3 3D Cell Culture and Fibrin Gel Construction 
 The 3D cell culture model of angiogenesis was modified from 




attach to gelatin-coated Cytodex® 3 microcarrier beads (Sigma-Aldrich, St. 
Louis, MO) as follows.  HUVECs were trypsinized, pelleted, counted, and 
4x106 cells were suspended in 5 ml of EGM-2.   This suspension was 
transferred into an upright T-25 culture flask with ten-thousand sterilized 
microcarrier beads and was gently agitated every 30 minutes.  After 4 
hours, the suspension was supplied with an additional 5 ml EGM-2 and 
moved to a fresh T-25, and incubated in normal cell culture position.  
Coated beads were used within 48 hours. 
 To create fibrin tissues for 3D cell cultures, 490 l of 2.5 mg/ml 
bovine fibrinogen (lot# 029K7636V, Sigma-Aldrich) solutions containing 
approximately 100 HUVEC-coated microcarrier beads were combined with 
10 l thrombin stock solution (50 U/ml, Sigma-Aldrich).  Then, 63 l of this 
mixture was quickly transferred into each well of the autoclaved PDMS 
multi-well plate.  Acellular fibrin gels used for confocal reflectance imaging 
were created in an identical manner using microcarrier beads with no 
HUVECs attached.  All gels were left at room temperature for 5 minutes to 
allow the beads to settle to the bottom of the well, and incubated an 
additional 25 minutes in a 37°C, 5.0% CO2 incubator to allow for complete 
gelation.  After incubation, 5,000 HASMCs were plated on top of each fibrin 




conditions were clamped into a linear stage and the cyclic strain protocol 
(10% strain, 0.7 Hz) commenced.  PDMS plates cultured statically were 
placed into petri dishes for sterility. Both strained and static conditions were 
cultured in a 37°C, 5.0% CO2 incubator.  Media was changed daily for all 
experiments in PDMS multi-well plates. 
 
3.2.4 Determination of the Kinetics and Robustness of Directional 
Sprouting 
 To determine the effects of cyclic strain on angiogenesis, cell-seeded 
PDMS multi-well slabs were prepared as described above, divided into 
static and stretched conditions, and cultured for 5 days.  On days 2 through 
5, all of the beads within each PDMS slab were imaged.    
 To determine the robustness of directional sprouting in this system, 
PDMS multi-well slabs were again prepared.  Two slabs were subjected to 
cyclic strain (Fig. 3-4 A, Groups 1 and 2), while two were left under static 
conditions initially (Fig. 3-4 A, Groups 3 and 4) for four days.  On day 4, 
plates were imaged.  After imaging, one of the previously strained samples 
was transferred to a static condition, while a previously unstrained PDMS 
slab was placed in the linear stage and subjected to cyclic strain (Fig. 3-4 




performed for each condition. 
 
3.2.5 Calibration of Strain in 3D Hydrogels 
 To determine the extent to which various levels of strain deform fibrin 
hydrogels embedded within the PDMS slab, 2.5 mg/ml fibrin gels 
containing Fluospheres® were prepared as described above and the 
PDMS slab was clamped into a custom-built microscope stage insert (Fig. 
3-1 B).  A micrometer attached to the insert was used to reposition the 
moving clamp to apply strain to the PDMS slab.  Determination of the 
internal strain in the gel was performed as previously described [14, 15].  In 
short, triads of fluorescent beads randomly distributed within the gel were 
imaged at 0-12% strain in increments of 2%.  Relative distances between 
these beads at each strain level were used to calculate the first and second 





3.2.6 Quantification of Network Length 
and Sprout Angle 
 Quantification of total network 
length was performed as described 
previously [13].   Briefly, vessels from 
each bead were traced using ImageJ 
software and summed to determine 
total network length.  For each 
condition, the network lengths of 
sprouts coming from 10 individual 
beads were averaged to determine the 
total average network length for that 
condition.  To determine the average 
angle of sprouts coming off of the 
bead, ImageJ software was used to 
measure the acute angle of each 
sprout as it projected from the bead 
relative to the direction of applied 
            (a) Representative 
image of a triad used in strain calibration. A 
system of equations was solved for E11, E12, 
and E22 and were used to calculate the principle 
strains.  Shown are the first (b) and second (c) 
principle strains within the fibrin matrix.  15 triads 
were used for this analysis. 
Figure 3-2. Relationship between applied strain 




strain (horizontal).  Angle measurements from each bead were averaged, 
followed by averaging of the results across 10 beads to determine the 
average sprout angle.  For all quantifications, 4 independent experiments 
were performed. 
 
3.2.7 Finite Element Model 
 To further analyze the local strain within the fibrin gel, a 2D finite 
element model of the strain field surrounding a single microcarrier bead 
was created using COMSOL Multiphysics (COMSOL Inc., Burlington, MA).  
The model assumes 10% uniaxial strain applied to a slab of fibrin gel 
containing the bead.  The fibrin surrounding the bead is modeled as an 
elastic solid of elastic modulus (E) 3147 Pa, Poisson’s ratio () of 0.4992, 
and density 2.5 mg/ml.  The diameter of the bead in the model is 150 m, 
which corresponds to the approximate diameter of the Cytodex beads used 
experimentally (after swelling).  The bead is modeled as a rigid solid of 
modulus 10MPa. 
 
3.2.8 Staining of HUVEC plasma membranes for imaging 
 To facilitate imaging, HUVEC plasma membranes were stained with 




NY).  Cells were washed once with DPBS, then incubated in DPBS 
containing 2.5 M SP-DiIC18(3) at 37°C for 5 minutes, followed by a 15 
minute incubation at 4°C to prevent endocytosis of the dye.  After the 
incubation at 4°C, a final DPBS wash was performed, and EGM-2 was 
replaced.   
 
3.2.9 Confocal Reflectance and Fluorescence Microscopy 
 Unlabeled fibrin matrices were visualized using confocal reflectance 
microscopy.  Confocal reflectance images were taken on a Zeiss LSM 510-
META Laser Scanning Confocal microscope using a 63x water immersion 
objective (C-Aprochromat, Carl Zeiss, Thornwood, NY).  Fibrin gels were 
illuminated using a 488 nm Argon laser through an 80/20 filter.  Other 
fluorescence images were taken on an Olympus IX81 microscope 
equipped with a 100-W high pressure mercury lamp (Olympus, Center 
Valley, PA) and Hammamatsu camera (Bridgewater, NJ).   
 
3.2.10 Statistical Analysis 
 Statistical analysis was performed using open source R software 
(www.r-project.org).  Two-way analysis of variance (ANOVA) was 




The threshold for statistical significance was set at p < 0.05.  Data are 
reported as mean ± SEM. 
 
3.3 Results 
3.3.1 Quantification of microscale strain confirms that strain applied to the 
PDMS propagates into the fibrin gel 
 The first step in this study was to confirm that strain applied to the 
PDMS slab was propagated into the fibrin, and to subsequently calibrate 
the measured strain with the applied strain.  To accomplish this goal, red 
fluorescent microcarrier beads were embedded in the fibrin gels.  
Displacements of the microspheres under strain (0-12%) were measured, 
revealing that the first principle strain in the system responded linearly (R2 
= 0.9297) to the applied strain (Fig. 3-2 B).  The second principle strain, a 
metric of strain in the direction orthogonal to the applied strain, showed a 
weaker, but still linear (R2 = 0.5336), negative trend with increasing applied 
strain (Fig. 3-2 C).  These calibration results show that uniaxial strain 





Figure 3-1. Effects of cyclic strain on angiogenesis.  (a, b) Representative pictures of HUVEC-coated 
dextran microcarrier beads at day 5 in 3D angiogenesis assay under strained (left) and static (right) 
conditions. (c) Normalized network lengths of strained and static capillaries. Data for each condition were 
normalized to the day 2 static condition. No significant differences were observed between the strained 
and static conditions at each time point. (d) A significant decrease in average sprout angle was observed 
in the strained conditions (relative to static) for all time points. Random alignment corresponds to an 
average angle of 45°, and perfect alignment in the direction of strain corresponds to 0°. Data reported as 
mean 6 SEM. Scale bars = 100 µm. 
3.3.2 Cyclic strain alters the direction, but not the magnitude, of angiogenic 
sprouting 
 Following calibration, we used our mechanical strain device to apply 
cyclic strain (10% strain, 0.7 Hz) to the 3D fibrin-based model of 
angiogenesis.  This regimen was chosen to conform with published 
experiments showing directional alignment in 3D assays [11, 16, 17].  
Representative images of capillaries formed under static and strained 




sprouting in strained versus control cultures.  No statistically significant 
differences in average total network lengths were observed between the 
strained and static conditions on days 2-5 (Fig. 3C).  However, significant 
differences were observed in sprouting direction.  By day 2, the static 
cultures contained capillary sprouts with an average sprout angle of 
39.9±7.1°, showing nearly perfectly random radial outward growth from a 
bead (Fig. 3D).  In contrast, cells in the strained cultures yielded capillary 
sprouts with an average sprout angle of 29.7±4.2°, significantly lower (p < 
0.05) than that for the static cultures (Fig. 3D). 
 
3.3.3 Direction of angiogenic sprouting is sensitive to changes in strain 
regimen  
 In order to test the stability of the directional biasing, four 
experimental groups were created (Fig. 4A).  The magnitude of capillary 
sprouting was not significantly different across any of these four groups at 
day 4 or 8 (Fig. 4B), consistent with the data presented earlier (Fig. 3C).  
By contrast, there were significant adjustments in sprout angle when the 
strain regimen was altered.  Image analysis revealed that the conditions 





Figure 3-2. Effects of a change in strain regimen on angiogenesis. A. Schematic depicting the four 
different experimental groups, each of which was quantified for total network length and average sprout 
angle on day 4 and day 8.  Strained conditions were subjected to 10% strain, 0.7Hz. B.  Quantification of 
network lengths, normalized to the day 4 unstrained condition, showed that the magnitude of sprouting 
was unaffected by changes in the strain regimen. C. Cells under strain showed biasing parallel to the 
direction of strain at day 4.  When the strain stimulus was removed, biasing disappeared.  @ and * are 
statistically different, $ and % are statistically different, # and & are statistically different. Other 
comparisons are either not significant or were not made.  Random alignment corresponds to an average 
angle of 45 degrees, while perfect alignment in the direction of strain corresponds to 0 degrees.  Data 
reported as mean +/- S.E.M.  
(Group 1) and the condition cultured statically for 8 days (Group 4)] showed 
no changes in the angle of capillary sprouting between days 4 and 8, as 
expected.  The condition that was cultured statically for 4 days then 
cyclically strained for 4 days (Group 3) showed a slightly negative, but not 
statistically significant, change in sprout angle at day 8.  In contrast, 
however, the condition that was strained for 4 days then cultured statically 
for 4 days (Group 2) showed a complete loss of directional biasing, with 
sprouts growing radially outward from the bead at day 8. 
 






Figure 3-3.  Confocal reflectance images of the fibrin matrix at days 2-5 of the angiogenesis assay. A,E. 
Day 2, B,F. Day 3, C,G. Day 4 D,H. Day 5 of the microcarrier bead angiogenesis assay.  A-D. Static 
conditions, E-H. Stretched conditions.  The asterisk in each image denotes the microcarrier bead. Images 
pseudo-colored green for clarity.  Scale bars = 50 µm.  
Confocal reflectance images of the angiogenesis assay, taken under static 
conditions on days 2-5, showed significant remodeling of the extracellular 
matrix caused by the invading endothelial cells, but no visible alignment of 
fibrin fibers (Fig. 5A-H).  To examine the strain field surrounding a 
microcarrier bead, a finite element model was generated (Fig. 6A, B).  
Under an applied strain of 10%, the model shows 10% first principle strain 
throughout the gel, as well as distortions to the strain field surrounding the 
embedded microcarrier.  Near the regions of the bead normal to the applied 
strain, the simulation shows strains increasing to approximately 14%; by 
contrast, near the regions of the bead tangential to the applied strain, the 





Figure 3-4. The effects of strain on ECM architecture. A-B. Linear elastic models of a fibrin hydrogel 
containing a microcarrier bead and subjected to 10% strain.  In both the x-y (A) and x-z (B) planes, strain 
is amplified on the left and right faces of the bead, normal to the applied strain; strain is dampened on the 
faces tangential to the applied strain. C, D, F, G. Confocal reflectance images of fibrin matrix surrounding 
a strained bead show modest fiber alignment when the gel is strained 10% (C,D) and random orientation 
when static (F,G).  The asterisk in each image denotes the microcarrier bead.  There appear to be no 
differences in matrix architecture far from any boundary condition in the strained (E) and unstrained (H) 
conditions.  FFT Analysis (I, J) of images D and G shows a similar degree of fiber alignment in the 
strained and static conditions in the horizontal direction, with moderate peaks at 0, 180, and 360 degrees. 




These data suggest that the microcarrier beads themselves can both 
slightly amplify and slightly dampen the applied strain, depending on the 
face of the bead considered. 
 Confocal reflectance images of acellular fibrin gels containing 
microcarriers, but no cells, were taken to complement the finite element 
model (Fig. 6C-F).  When imaged under 10% strain, only modest alignment 
of the fibrin fibers parallel to the direction of strain was observed (Fig. 6C-
D, strain direction is horizontal) when visually compared to the unstrained 
conditions (Fig. 6E-F).  Reflectance pictures of acellular gels containing no 
beads (Fig. 6G-H) showed no visual difference in fiber alignment between 
strained and unstrained conditions. 
 To further characterize the orientation of the fibers under static and 
strained conditions, Fourier transforms of the images in Figs. 6D and 6G 
were generated and analyzed using NIH ImageJ (Figs. 6I and 6J).  
Computed intensity values for each angle represent the degree of fiber 
orientation in the image at that angle.  Results normalized to the raw values 
computed at 0° in each image show slight peaks in intensity at 0°, 180°, 
and 360°, indicating some possible alignment of the fibers in the horizontal 
direction; however, there were no significant differences in these peaks 






In this study, we developed and characterized a custom-made 
mechanical strain device that supports a 3D co-culture model of angiogenic 
sprouting widely used in the literature [12, 13, 16, 18].  With this new 
device, we showed here that cyclic strain applied to endothelial cells in a 
3D hydrogel controls angiogenic pattern formation.  Specifically, cyclic 
strain promoted alignment parallel to the direction of strain when the strain 
regimen was initiated at the beginning of the culture period.  Moving 
strained samples to a static environment caused a randomization of sprout 
angle, implying that the direction of sprouting does have a degree of 
plasticity even after vessels have formed.  Applying cyclic strain to the 
cultures after vessel-like structures had already formed induced a slight 
change in the subsequent sprouting direction as well, but the change was 
not quite statistically significant. However, the challenge of accurately 
measuring changes in capillary orientation in a pre-formed network without 
a fixed starting point may have contributed to an increased measurement 
uncertainty in this particular condition. 
 The results of our study here add to the growing body of evidence 




the formation of capillary networks.  However, consensus has not been 
reached as to whether mechanical forces positively or negatively influence 
vessel growth due to many contradictory studies.  For example, Kilarski, et 
al. showed that forces generated by endogenous fibroblasts promote the 
development and growth of new vessels during wound healing in vivo [19].  
By contrast, Boerckel, et al. recently showed that externally applied 
mechanical loads can actually reduce vessel invasion in a bone injury 
model when applied at early time points, while enhancing vascular 
remodeling when the load is applied after a delay [20].  Our quantitative 
data here show that ECs subjected to cyclic strain form capillary networks 
to the same extent as those cultured in static conditions, similar to a study 
by Krishnan, et al. which found no differences in segment length 
distribution in strained and unstrained collagen gels [17]. Beyond the 
magnitude of capillary sprouting, there are also contradictory publications 
with respect to the influence of applied strain on directionality.  Our 
observation that capillary sprouting occurs parallel to the direction of 
applied strain is consistent with the Krishnan, et al. study in which new 
sprouts initiated from isolated microvessels embedded in 3D collagen gels 
aligned parallel to the direction of applied cyclic strain (6% strain, 1 Hz) 




reported sprouting in a direction perpendicular to the applied cyclic strain 
[11]. 
 In order to put our results in the context of these earlier studies, it is 
important to understand two key differences with respect to our model 
system and data.  First, our model system contains a monolayer of smooth 
muscle cells on top of the fibrin gel.  In prior studies using our model, we 
have found that some type of stromal cell is essential to stimulate the 
HUVECs to form robust capillary-like structures with hollow, well-defined 
lumens [21, 22].  These supporting cells may fundamentally alter the 
mechanics of the matrix under strain, the behavior of the endothelial cells in 
their presence, or a combination of those factors. However, our 
experiments with HUVECs alone did not induce alignment perpendicular to 
the applied strain in our system, but instead compromised the formation of 
sprouts altogether (data not shown).  
A second important distinction of our findings is our data showing that 
cyclic strain did not significantly align the fibrin matrix, at least as detected 
via confocal reflection microscopy. On one hand, this finding is consistent 
with those of Matsumoto, et al., who showed that cyclic strain of 7% 
amplitude did not induce any perceptible alignment of fibrin fibrils [23].  On 




response to endothelial cell-generated tensile forces caused directional 
sprouting [10].  A more recent study showed that endothelial sprouting from 
spheroids occurred in a directional fashion in fibrin gels that had been 
aligned via an applied magnetic field or EC-generated forces [24].  In our 
model system, the mechanism by which applied strain induced directional 
alignment of the capillary-like networks is not simply explained by ECM 
realignment and contact guidance.  The randomization of capillary 
sprouting after the strain is removed further supports this statement, and 
implies that any subtle strain-induced local anisotropies in matrix 
architecture are not permanent.   
While we cannot rule out that subtle ECM realignment may play a 
role in directional capillary sprouting in our system, an alternative 
explanation is that the applied strain may induce local changes in ECM 
stiffness, without significantly disrupting fiber architecture. A previous study 
has shown that fibrin begins strain stiffening at approximately 10% strain, 
and that this stiffening occurs before fiber alignment can be detected by 
birefringence [25].  Matrix alignment itself can also increase the apparent 
stiffness of the ECM in the direction of alignment [26], but any potential 
change in local fibrin mechanics here in our study occurred independently 




therefore possible local matrix strain stiffening is rarely examined.  To 
address the question of how strain affects local matrix mechanics and cell 
behavior, Kotlarchyk et al. showed that applied strain induces local 
changes to fibrin stiffness in 3D gels, leading to differential cell behavior in 
regions of different stiffness [27].  Our finite element results showing strain 
amplification on the face of the bead normal to the strain direction agree 
with previous work showing that a rigid inclusion on a deformable 
membrane [28], as well as in a fibrin gel [29], can cause strain amplification 
in the vicinity of the inclusion.  Although strain stiffening in fibrin begins at 
10% strain, strain amplification around microcarriers may cause substantial 
strain, and stiffness, gradients.   
  Our data show that cyclic strain can be used to produce directional 
capillary growth during angiogenesis without a diminishing the extent of 
network formation, which is encouraging from a tissue engineering 
perspective.  It has already been established that the implantation of a pre-
vascularized tissue improves the rate of anastomosis with the host 
vasculature [30], an important factor in the survival of large tissue implants.  
Pre-vascularization and alignment will be important in engineered 
metabolic tissues which require alignment to function properly, such as 




environment surrounding cells undergoing complex morphogenetic 
programs improves, it will illuminate the engineering parameters necessary 
to create large, implantable tissues.  Finally, we highlight an interaction 
between a tissue and a rigid boundary, providing insight into the interaction 
between implanted medical devices and the surrounding vasculature.  In 
light of the modeling data presented here and the pronounced angiogenic 
response surrounding a microcarrier bead, understanding the mechanical 
environment surrounding an implant is necessary to effectively combat, or 
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Chapter 4  
 
Endothelial Response to Cyclic Strain is Unhindered 
by Modulation of Cell Traction Force  
 
4.1 Introduction 
 Biological systems almost universally contain intricate patterns that 
help to optimize tissue function.  For example, the lung is highly branched 
to maximize vascular surface area and promote gas exchange, and in 
cardiac muscle capillaries align parallel to the tissue mimicking its aligned 
conformation [1].  Although the presence of patterns is ubiquitous, how they 
are formed remains subject to debate.  Morphogen gradients have been 
shown to be important in certain types of pattern formation, but they do not 
fully explain the complex patterns seen in many tissues [2]. 
 Integrin connections link the cytoskeleton to the ECM, mechanically 
coupling the cell to its surroundings, and allowing the cell to be an active 




mechanical cues such as extracellular matrix (ECM) stiffness, cell-
mediated traction forces, and strains applied to the ECM have been shown 
to influence cell migration [3, 4] and pattern formation [5-7], especially in 
the context of angiogenesis, and there is considerable evidence linking 
cytoskeletal dynamics to these phenomena [8].  The small GTPase RhoA is 
of particular significance as a regulator of cytoskeletal organization and 
traction force generation [9, 10] and it is known to modulate endothelial cell 
responses to shear stress during migration and angiogenesis [11, 12].  
More broadly, however, endothelial cell traction force generation, regulated 
by RhoA and other participants in the pathway leading to actomyosin-
generated traction force, are critical for robust angiogenesis [13]. 
 Cells regulate their cytoskeletal conformation in response to changes 
in stiffness and applied forces [14].  In addition, they are believed to sense 
mechanical forces via their cytoskeletal components, and impairment of 
these structures impairs their mechanosensitivity [15, 16].  This effect is 
well-characterized in 2D but has not been studied as extensively in 3D 
systems, especially in the context of complex morphogenetic programs like 
angiogenesis.  Although it has been suggested that angiogenic sprouting 
will follow contact guidance cues mediated by aligned collagen fibers [17], 




to low magnitude strains, has not been definitively established [6, 18, 19]. 
 By adapting a system originally developed by Nehls and Drenckhahn 
to recapitulate angiogenesis in fibrin gels [20], we have designed a 
bioreactor capable of applying cyclic strain to an in vitro model of 
angiogenesis.  Previous studies using this system have shown that sprouts 
form parallel to the direction of strain, but the mechanism by which this 
occurs remains to be elucidated [6].  Here we explore the effects of cyclic 
strain on angiogenesis in the presence of multiple genetic and 
pharmacological modulators of cell traction force, specifically chosen to 
explore a pathway involved in regulating, sensing, and responding to cell-
mediated and externally-imposed forces, to test the hypothesis that this 
pathway is involved in the persistent directional sprouting of angiogenic 
capillaries in the presence of cyclic strain. 
  
4.2 Methods 
4.2.1 Cell Culture 
 HUVECs were isolated from fresh umbilical cords as described 
previously [21].  In brief, cord veins were cannulated and residual blood 
was flushed out with sterile Dulbecco’s phosphate buffered saline (DPBS, 




Lakewood, NJ) digestion was performed for 15 minutes at 37°C to release 
endothelial cells from the vessel wall.  The vessel was again flushed with 
DPBS and the cell suspension was centrifuged, re-suspended in 
Endothelial Growth Medium 2 (EGM-2, Lonza, Walkersville, Maryland), and 
plated.  Cells were washed with DPBS after 24 hours to remove residual 
erythrocytes.  HUVECs were expanded to passage 2 and frozen.  All 
microcarrier bead assays were performed with HUVECs at passage 3.  
Human aortic smooth muscle cells (HASMCs, Cascade Biologics, Portland, 
OR) were cultured in M231 supplemented with smooth muscle growth 
supplement (Life Technologies, Grand Island, NY).  Medium was changed 
every other day.  All cell culture was performed in a 37°C, 5% CO2 
incubator. 
 
4.2.2 Modulation of Endothelial Cell Traction Force by Application of 
Cytoskeletal Inhibitors 
 Three drugs were chosen to inhibit cell traction force generation: 
Y27632 (EMD Millipore, Billerica, MA), which inhibits Rho-associated 
protein kinase (ROCK) activity and subsequently myosin light chain 
phosphorylation via ROCK; ML-7 (Sigma-Aldrich, St. Louis, MO), which 




chain phosphorylation via MLCK; and the myosin ATPase inhibitor 2,3-
butanedione 2-Monoxime  (BDM, Calbiochem).  Concentrations used in 
angiogenesis experiments were as follows: Y27632 at 30 M, ML-7 at 10 
M, BDM at 10 mM, chosen based on previous studies from our laboratory 
[13, 22]. 
 
4.2.3 Creation of RhoA Mutant Constructs and Transduction 
 The mutant RhoA and eGFP transgenes were subcloned from 
pcDNA3-EGFP-RhoA-Q63L (constitutively active form of RhoA, Addgene 
plasmid 12968), and pcDNA3-EGFP-RhoA-T19N (dominant negative form 
of RhoA, Addgene plasmid 12967).  The transgenes were then inserted 
into the multiple cloning site of a tetracycline inducible backbone, TetO-
FUW-MCS, derived from Addgene plasmid 20321 (TetO-FUW-OSKM) to 
construct the plasmids TetO-FUW-eGFP-RhoA-Q63L, TetO-FUW-eGFP-
RhoA-T19N, and TetO-FUW-eGFP.  HUVECs were transduced with the 
respective viruses at a multiplicity of infection of approximately 1.5 in the 
presence of 8 g/ml Polybrene (EMD Millipore. Cat# TR-1003-G). 
 
4.2.4 Pull-down Assay, SDS-PAGE, and Immunoblotting 




eGFP control, were lysed on ice in modified RIPA buffer without SDS (50 
mM Tris, pH 7.6, 150 mM NaCl, 10 mM MgCl2, 1% TritonX-100, 1 mM 
PMSF, 10 g/ml leupeptin, 10 g/ml aprotinin, 1 mM NaVO4, 0.5 g/ml 
pepstatin A).  Lysates were cleared by centrifugation and protein 
concentration was determined by bicinchoninic acid assay.  To verify the 
activity of the RhoA mutants, pull-down assays were performed as follows.  
Equal masses of protein were incubated with 30 g of Rhotekin-RBD 
Protein GST Beads (Cytoskeleton, Denver, CO) at 4 °C for 1 hour, 
collected by centrifugation and washed with lysis buffer.  After the final 
wash the supernatant was aspirated, 25 l Laemmli sample buffer was 
added to the bead slurry was heated to 95 °C for 10 minutes then run on a 
16% polyacrylamide gel.  Presence of total mutant protein was determined 
similarly, without the pull-down step.  All samples were subjected to SDS-
polyacrylamide gel electrophoresis after which protein was transferred to a 
PVDF membrane for immunoblotting.  PVDF membranes were blocked 
with 5% BSA in Tris-buffered saline plus 0.1% Tween 20 (TBST) for 2 
hours, followed by incubation with a mouse anti-human RhoA antibody in 
TBST containing 5% BSA for an additional 2 hours (Santa Cruz 
Biotechnology, Dallas, TX).  After 6 10-minute washes, membranes were 




Cruz Biotechnology, Dallas, TX) for 2 hours, washed as before, and 
detected via an enhanced chemiluminescence detection system.  
Quantification of immunoblots was performed using NIH ImageJ software. 
 
4.2.5 Fibrin Tissue Construction and Application of Cyclic Strain 
 Fibrin tissues were constructed as previously described [6].  HUVECs 
were trypsinized, counted, and 4 x 106 were suspended with ten-thousand 
Cytodex® 3 microcarrier beads (Sigma-Aldrich, St. Louis, MO) in 5 ml of 
EGM-2 in an upright T-25 flask. The flask was gently agitated every 30 
minutes.  After 4 hours an additional 5 ml EGM-2 was added to the flask 
and the entire suspension was transferred to a fresh T-25 and incubated in 
normal cell culture position.  The next day, 490 l of fibrinogen (Sigma-
Aldrich, St. Louis, MO) solution containing 100 microcarrier beads coated 
with the appropriately transduced, or non-transduced, HUVECs was 
combined with 10 l 50 U/ml thrombin stock solution (Sigma-Aldrich, St. 
Louis, MO) and 63 l of this solution was pipetted into each well of a PDMS 
multi-well plate.  All gels were left at room temperature for 5 minutes to 
allow the beads to settle, then were cultured at 37°C for an additional 25 
minutes to allow for complete gelation.  After generation of the fibrin gel, 




were added to the top of each fibrin gel.  Within 30 minutes of plating, 
PDMS multi-well plates used in strained conditions were loaded onto linear 
stages and 10% strain was applied at 0.7 Hz.  All fibrin tissues were 
cultured in a 37°C, 5% CO2 incubator. 
 
4.2.6 Quantification of Network Length and Sprout Angle 
 Quantification of total network length was performed as described 
previously [6, 21]. For each condition, vessels branching from at least 10 
beads were traced using ImageJ software and averaged to determine total 
average network length.  ImageJ software was also used to measure the 
acute angle of each sprout as it projected from the bead relative to the 
direction of applied strain (horizontal) to determine the angle at which 
capillaries sprouted from the bead.  Angle measurements from each bead 
were averaged, followed by averaging of the results across at least 10 
beads to determine the average sprout angle.  For all quantifications, at 
least three independent experiments were performed. 
 
4.2.7 Statistical Analysis 
 Statistical analysis was conducted with open source R software 




0.05.  Data are reported as mean ± 95% confidence interval. 
 
4.3 Results 
4.3.1 Transduced HUVECs Express RhoA Mutants 
 Western blots and pull-down assays were performed to verify that 
HUVECs transduced with RhoA mutants Q63L (constitutively active) and 
T19N (dominant negative) expressed the proteins in question and to verify 
their activity.  Expression of all three constructs (including eGFP) was also 
verified by fluorescence microscopy (data not shown).  Western blotting for 
RhoA indicated that in the presence of 100 ng/ml and 0 ng/ml doxycycline 
the Q63L-RhoA and T19N-RhoA constructs showed high and low levels of 
construct expression, respectively (Figure 4-1 A).  Notably, both proteins 
showed a basal level of expression in the absence of doxycycline.  Pull-
down assays confirmed the activity of Q63L-RhoA and the presence of a 
basal level of expression of this construct (Figure 4-1 B).  Activity levels of 
T19N-RhoA were below the levels of Q63L-RhoA in the 100 ng/ml and 0 
ng/ml doxycycline conditions (Figure 4-1 B), despite comparable total 





Figure 4-1. RhoA construct expression is modulated by doxycycline concentration.  (A) Quantification of 
Western blots showing total Q63L-RhoA and T19N-RhoA construct in the presence of 100 ng/ml or 0 
ng/ml doxycycline.  Both constructs are expressed equally in the presence of equal concentrations of 
doxycycline, and both show decreased expression when doxycycline is not present.  (B) Quantification of 
pull-down assay indicating the presence of GTP-bound constructs.  When induced by doxycycline the 
RhoA-Q63L shows strong expression.  A basal level of expression persists even in the absence of 
doxycycline.  The T19N-RhoA construct shows a low level of activity in the presence of doxycycline and 
nearly zero activity in its absence.  Conditions with * are statistically different from each other (p < 0.05).  
Data is reported as mean +/- S.E.M. 
 
4.3.2 Presence of RhoA Mutants Affects Network Length but Not Capillary 
Alignment 
 Angiogenesis assays using transduced HUVECs coated onto 
microcarrier beads were performed to determine if altered RhoA activity in 
endothelial cells affected capillary network length or alignment in the 
presence of cyclic strain.  In assays carried out to day 4 (Figure 4-2) and 
day 8 (Figure 4-3) the expression of either RhoA mutant led to a decrease 
in average network length relative to the eGFP control under both static 





Figure 4-2. Presence of RhoA mutants affects network length but not directional sprouting at day 4.  (A, 
D) eGFP transduced HUVECs at day 4, (B, E) T19N-RhoA transduced HUVECs at day 4, (C, F) Q63L-
RhoA transduced HUVECs at day 4.  (G) Presence of a RhoA mutant decreases the network length 
relative to eGFP control under both static and strained conditions.  The magnitude of this decrease is 
greater for the Q63L-RhoA mutant.  (H) The presence of either a RhoA mutant or the eGFP control has 
no effect on the directional biasing induced by cyclic strain. Columns with * are statistically different from 




significantly reduce network length in both the control and T19N-RhoA 
conditions but not the Q63L-RhoA condition on both days. 
 Expression of the mutants had no effect on capillary alignment in the 
presence of cyclic strain.  Static controls displayed radial outgrowth with 
average sprout angles of approximately 45 degrees at both day 4 (Figure 
4-2 H) and day 8 (Figure 4-3 H).  By contrast, growth of cyclically strained 
HUVECs was biased in the direction parallel to the applied strain and this 
bias was unaffected by the presence of either the constitutively active 
(Q63L) or dominant negative (T19N) RhoA mutants. 
 
4.3.3 Pharmacological Inhibition of Cell Traction Force Affects Network 
Length but not Capillary Alignment 
 To modulate cell traction force, hydrogels were treated with the drugs 
BDM (an inhibitor of myosin ATPase), ML7 (an inhibitor of myosin light 
chain kinase), and Y27632 (an inhibitor of ROCK).  Treatment with all of 
the drugs except for ML7 produced networks of similar length at day 4 
(Figure 4-4 G) or eight (Figure 4-5 G).  Interestingly, ML7 produced 
capillary networks of widely varying length that were, on average, longer 
than those produced in the presence of the other drugs.  None of the drugs 





Figure 4-3. Presence of RhoA mutants affects network length but not directional sprouting at day 8.  (A, 
D) eGFP transduced HUVECs at day 8, (B, E) T19N-RhoA transduced HUVECs at day 8, (C, F) Q63L-
RhoA transduced HUVECs at day 8.  (G) Presence of a RhoA mutant decreases the network length 
relative to eGFP control under both static and strained conditions.  The magnitude of this decrease is 
greater for the Q63L-RhoA mutant.  (H) The presence of either a RhoA mutant or the eGFP control has 
no effect on the directional biasing induced by cyclic strain.  Columns with * are statistically different from 






day 4 or 8 (Figure 4-4 H and Figure 4-5 H), indicating that the presence of 
these drugs does not prevent HUVECs from sensing their mechanical 
microenvironment despite inhibition of their ability to apply traction force. 
 
4.4 Discussion 
 We have previously shown that HUVECs induced to undergo 
angiogenesis while being exposed to cyclic strain produce capillaries that 
are aligned parallel to that strain [6].  However, the mechanism that caused 
this effect remained unclear.  We aimed to test the hypothesis that during 
angiogenesis, HUVECs used a RhoA-dependent mechanism to sense local 
forces and determine their direction of growth.  This pathway is known to 
be involved in the generation of cytoskeletal pre-stress, which closely 
couples the strain state of the cell with that of the ECM [23].  Transduction 
with inducible dominant negative and constitutively active RhoA mutants 
allowed for modulation of RhoA activity, and thus the state of pre-stress, 
within the cultured HUVECs.  We subsequently demonstrated that changes 
in RhoA activity had no effect on the alignment of our cultured HUVECs in 
the presence of cyclic strain, although significant decreases in network 





Figure 4-4. Modulation of cell traction force affects both network length and sprout angle.  (A, D) HUVECs 
treated with BDM at day 4, (B, E) HUVECs treated with ML7 at day 4, (C, F) HUVECs treated with 
Y27632 at day 4.  (G) Modulation of traction force produced no statistical differences between static 
controls and strained conditions treated with the same drug, indicating that strain neither counteracts nor 
amplifies the effects of drug treatment. (H) All strained networks have lower average sprout angles than 
their static controls, implying that the drugs did not affect their ability to align parallel to the applied strain.  
Columns with * are statistically different from corresponding condition with $ (p < 0.05).  Data is reported 




that ECs expressing constitutively active V14-RhoA exhibited increased 
angiogenic sprouting [24, 25], we believe that in this case the decreases in 
network length found in HUVECs expressing our constructs are due to 
leaky expression of the constructs as shown in Figure 1.  In the case of the 
Q63L mutant, it appears that the levels of RhoA mutant generated by the 
construct is so great, even when not induced, that the traction force 
produced by the ECs goes beyond the pro-angiogenic optimum seen 
previously to an over-contractile, less angiogenic state. 
This finding led us to expand our search to include three downstream 
effectors: ROCK, MLCK, and Myosin ATPase to better parse where, and if, 
this pathway sensed the applied strain.  We observed varying levels of 
network formation in both static and strained tissues at both time points, as 
shown previously [6, 26], but presence of the drugs did not inhibit capillary 
alignment parallel to the direction of strain at either time point. 
Neither Y27632 nor ML7 altered the alignment behavior of the 
angiogenic capillaries.  ROCK is a known regulator of cell polarity [27] and 
is directly involved in traction force generation during cell migration [28], yet 
inhibition of this protein did not result in detectable changes in cell 
alignment in the presence of cyclic strain.  This is not completely surprising 





Figure 4-5 Modulation of cell traction force affects both network length and sprout angle.  (A, D) HUVECs 
treated with BDM at day 8, (B, E) HUVECs treated with ML7 at day 8, (C, F) HUVECs treated with 
Y27632 at day 8.  (G) Modulation of traction force produced no statistical differences between static 
controls and strained conditions treated with the same drug, indicating that strain neither counteracts nor 
amplifies the effects of drug treatment. (H) At day 8 all strained networks have lower means than their 
corresponding static controls, indicating alignment parallel to strain.  Columns with * are statistically 
different from corresponding condition with $ (p < 0.05).  Data is reported as mean +/- S.E.M. Scale bars 





tumor microenvironment, inhibition of ROCK can encourage normal 
responses to mechanical stimuli [29] and improve vessel function.  Thus, 
sub-physiological ROCK activity may still allow the endothelial cells to 
polarize and migrate in response to mechanical cues.  Also, strain is a 
known activator of the RhoA/ROCK pathway.  While the application of an 
inhibitor may somewhat decrease this [30], it does not interfere with 
alignment in our system.  Interestingly, application of ML7 and Y27632 to 
endothelial cells on 2D substrates has been shown to reverse the 
polarizing cue, causing stress fiber alignment parallel to the applied strain, 
rather than perpendicular as in the control cells [31].  By contrast, in 3D and 
while undergoing angiogenesis, our results show that HUVECs are robust 
to perturbations of their traction force generating pathways and consistently 
align parallel to the strain direction.  Stress fibers in 3D matrices may play a 
lesser role than they appear to play in 2D, as evidenced by their lack of 
prominence in 3D matrices [32], and thus disruption of the signaling 
pathways controlling them may be less influential over directional cell 
migration. 
Additionally, BDM, a myosin ATPase inhibitor, failed to prevent 
capillaries from aligning parallel to the strain direction.  This suggests that 




hypothesis that traction force production and mechanosensing are 
controlled by different pathways in endothelial cells during angiogenesis.  
However, BDM is only a moderately specific myosin inhibitor, strongly 
inhibiting myosin II but not several other myosin isoforms [33].  It is also an 
inhibitor of calcium influx in muscle and non-muscle cells [34, 35].  These 
disadvantages indicate that the use of BDM should be complemented with 
alternative myosin inhibitor, such as blebbistatin, a drug capable of broader 
myosin inhibition [36], in future experiments. 
  Alternatively, the strain applied to our system may be overcoming 
the effects of cell traction force inhibition by tensing the cellular force 
transduction elements independently of actomyosin contractility.  For 
example, actin stress fibers treated with the drugs used in this study most 
likely exhibit decreased levels of pre-stress, similarly to how cells under 
sudden compression display buckled actin stress fibers [37].  Normal levels 
of pre-stress were recovered after application of strain, and it is possible 
that the applied strain in our system similarly compensates for a lack of pre-
stress in our capillary ECs.  This could be tested by lowering the strain 
amplitude applied to the system to determine at what point the application 
of strain no longer induced capillaries to align in the presence and absence 




actomyosin contraction increases integrin-ECM bond strength, which has 
been shown to be enhanced by applied strains even in the presence of 
BDM [38].  Similarly, applied strain in our system may be compensating for 
the decrease in actomyosin-generated tension and overcoming any loss of 
mechanosensitivity due to inhibitory drugs. 
  
4.5 References 
[1] Bassingthwaighte JB, Yipintsoi T, Harvey RB. Microvasculature of the 
dog left ventricular myocardium. Microvasc Res 1974;7:229-49. 
 
[2] Lander AD. Pattern, growth, and control. Cell 2011;144:955-69. 
 
[3] Peyton SR, Putnam AJ. Extracellular matrix rigidity governs smooth 
muscle cell motility in a biphasic fashion. J Cell Physiol 2005;204:198-209. 
 
[4] Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H, Kamm 
RD, et al. Migration of tumor cells in 3D matrices is governed by matrix 
stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad 
Sci U S A 2006;103:10889-94. 
 
[5] Ingber DE. Mechanical signaling and the cellular response to 
extracellular matrix in angiogenesis and cardiovascular physiology. Circ 
Res 2002;91:877-87. 
 
[6] Ceccarelli J, Cheng A, Putnam AJ. Mechanical Strain Controls 
Endothelial Patterning During Angiogenic Sprouting. Cellular and Molecular 
Bioengineering 2012;5:463-73. 
 
[7] Kilarski WW, Samolov B, Petersson L, Kvanta A, Gerwins P. 
Biomechanical regulation of blood vessel growth during tissue 





[8] Mammoto A, Ingber DE. Cytoskeletal control of growth and cell fate 
switching. Curr Opin Cell Biol 2009;21:864-70. 
 
[9] Hanley PJ, Xu Y, Kronlage M, Grobe K, Schon P, Song J, et al. 
Motorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility. 
Proc Natl Acad Sci U S A 2010;107:12145-50. 
 
[10] Provenzano PP, Keely PJ. Mechanical signaling through the 
cytoskeleton regulates cell proliferation by coordinated focal adhesion and 
Rho GTPase signaling. J Cell Sci 2011;124:1195-205. 
 
[11] Shiu YT, Li S, Marganski WA, Usami S, Schwartz MA, Wang YL, et al. 
Rho mediates the shear-enhancement of endothelial cell migration and 
traction force generation. Biophys J 2004;86:2558-65. 
 
[12] Song JW, Daubriac J, Tse JM, Bazou D, Munn LL. RhoA mediates 
flow-induced endothelial sprouting in a 3-D tissue analogue of 
angiogenesis. Lab Chip 2012;12:5000-6. 
 
[13] Kniazeva E, Putnam AJ. Endothelial cell traction and ECM density 
influence both capillary morphogenesis and maintenance in 3-D. Am J 
Physiol Cell Physiol 2009;297:C179-87. 
 
[14] Wang JH, Goldschmidt-Clermont P, Yin FC. Contractility affects stress 
fiber remodeling and reorientation of endothelial cells subjected to cyclic 
mechanical stretching. Ann Biomed Eng 2000;28:1165-71. 
 
[15] Iba T, Sumpio BE. Morphological response of human endothelial cells 
subjected to cyclic strain in vitro. Microvasc Res 1991;42:245-54. 
 
[16] Shirinsky VP, Antonov AS, Birukov KG, Sobolevsky AV, Romanov YA, 
Kabaeva NV, et al. Mechano-chemical control of human endothelium 
orientation and size. J Cell Biol 1989;109:331-9. 
 
[17] Krishnan L, Underwood CJ, Maas S, Ellis BJ, Kode TC, Hoying JB, et 
al. Effect of mechanical boundary conditions on orientation of angiogenic 
microvessels. Cardiovasc Res 2008;78:324-32. 
 
[18] Korff T, Augustin HG. Tensional forces in fibrillar extracellular matrices 





[19] Matsumoto T, Yung YC, Fischbach C, Kong HJ, Nakaoka R, Mooney 
DJ. Mechanical strain regulates endothelial cell patterning in vitro. Tissue 
Eng 2007;13:207-17. 
 
[20] Nehls V, Drenckhahn D. A novel, microcarrier-based in vitro assay for 
rapid and reliable quantification of three-dimensional cell migration and 
angiogenesis. Microvasc Res 1995;50:311-22. 
 
[21] Ghajar CM, Blevins KS, Hughes CC, George SC, Putnam AJ. 
Mesenchymal stem cells enhance angiogenesis in mechanically viable 
prevascularized tissues via early matrix metalloproteinase upregulation. 
Tissue Eng 2006;12:2875-88. 
 
[22] Kniazeva E, Weidling JW, Singh R, Botvinick EL, Digman MA, Gratton 
E, et al. Quantification of local matrix deformations and mechanical 
properties during capillary morphogenesis in 3D. Integr Biol (Camb) 
2012;4:431-9. 
 
[23] Chiquet M, Renedo AS, Huber F, Flück M. How do fibroblasts translate 
mechanical signals into changes in extracellular matrix production? Matrix 
biology 2003;22:73-80. 
 
[24] Hoang MV, Whelan MC, Senger DR. Rho activity critically and 
selectively regulates endothelial cell organization during angiogenesis. 
Proc Natl Acad Sci U S A 2004;101:1874-9. 
 
[25] Kniazeva E, Weidling JW, Singh R, Botvinick EL, Digman MA, Gratton 
E, et al. Quantification of local matrix deformations and mechanical 
properties during capillary morphogenesis in 3D. Integr Biol (Camb) 
2012;4:431-9. 
 
[26] Kniazeva E, Putnam AJ. Endothelial cell traction and ECM density 
influence both capillary morphogenesis and maintenance in 3-D. Am J 
Physiol Cell Physiol 2009;297:C179-87. 
 
[27] Daley WP, Gervais EM, Centanni SW, Gulfo KM, Nelson DA, Larsen 
M. ROCK1-directed basement membrane positioning coordinates epithelial 





[28] Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during 
angiogenesis. Circ Res 2007;100:782-94. 
 
[29] Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber 
DE. Tumor-derived endothelial cells exhibit aberrant Rho-mediated 
mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci U 
S A 2008;105:11305-10. 
 
[30] Teramura T, Takehara T, Onodera Y, Nakagawa K, Hamanishi C, 
Fukuda K. Mechanical stimulation of cyclic tensile strain induces reduction 
of pluripotent related gene expressions via activation of Rho/ROCK and 
subsequent decreasing of AKT phosphorylation in human induced 
pluripotent stem cells. Biochem Biophys Res Commun 2012;417:836-41. 
 
[31] Lee CF, Haase C, Deguchi S, Kaunas R. Cyclic stretch-induced stress 
fiber dynamics - dependence on strain rate, Rho-kinase and MLCK. 
Biochem Biophys Res Commun 2010;401:344-9. 
 
[32] Hakkinen KM, Harunaga JS, Doyle AD, Yamada KM. Direct 
comparisons of the morphology, migration, cell adhesions, and actin 
cytoskeleton of fibroblasts in four different three-dimensional extracellular 
matrices. Tissue Eng Part A 2011;17:713-24. 
 
[33] Ostap EM. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor. J 
Muscle Res Cell Motil 2002;23:305-8. 
 
[34] Sellin LC, McArdle JJ. Multiple effects of 2,3-butanedione monoxime. 
Pharmacol Toxicol 1994;74:305-13. 
 
[35] Zhu Y, Ikeda SR. 2,3-butanedione monoxime blockade of Ca2+ 
currents in adult rat sympathetic neurons does not involve 'chemical 
phosphatase' activity. Neurosci Lett 1993;155:24-8. 
 
[36] Limouze J, Straight AF, Mitchison T, Sellers JR. Specificity of 
blebbistatin, an inhibitor of myosin II. J Muscle Res Cell Motil 2004;25:337-
41. 
 
[37] Lu L, Feng Y, Hucker WJ, Oswald SJ, Longmore GD, Yin FC. Actin 






[38] Friedland JC, Lee MH, Boettiger D. Mechanically activated integrin 







Chapter 5  
Conclusions and Future Directions 
5.1 Contributions of This Dissertation 
 This work has demonstrated that the application of cyclic strain 
causes capillaries formed during angiogenesis to form parallel to the 
applied strain.  It has also demonstrated that this alignment is robust to 
treatments known to modulate the ability of endothelial cells to apply 
traction to their surroundings. Three specific aims were addressed to 
formulate these conclusions. 
 
Specific Aim 1 
Build and characterize a bioreactor to apply cyclic strain to hydrogels. 
Specific Aim 2 
Study the effects of strain on angiogenesis 
Specific Aim 3 
Understand how the interplay between cellular traction force and 





 One cell culture platform and two devices were created to support the 
completion of these aims.  The cell culture platform was created from 
PDMS, a biocompatible silicone elastomer commonly used in microfluidic 
applications for cell culture.  Static and cyclic strains were applied to this 
platform using either of two devices.  The first of these can be mounted on 
a microscope stage for visualization of the ECM under load, and the 
second can apply cyclic or static strains to the PDMS platform under cell-
culture conditions.  Using these devices, it was demonstrated that 
angiogenesis occurs parallel to the direction of applied strain and that the 
alignment is reversible if subsequent culture is performed at 0% strain.  It 
was also discovered that cell-mediated remodeling of the ECM was not a 
significant factor in capillary alignment and that ECM alignment was 
modest under 10% applied strain.  Modulation of a mechanosensitive 
biochemical pathway involving RhoA, ROCK, MLCK, and myosin ATPase 
revealed that inhibition of this pathway does not diminish the directional 
response to applied strain. 
5.2 Expanded Summary 
 Fulfillment of Specific Aim 1 required the development of 2 devices 




PDMS platform required designing a device for the application of static 
strain: a microscope stage-insert containing a clamp and micrometer for 
applying precise strain to the PDMS culture plate.  This allowed hydrogels 
within the plate to be visualized while under strain.  Lagrangian finite strain 
analysis performed on 1 m fluorescent beads embedded in the fibrin gel 
revealed a linear relationship between the applied strain and the strain 
present in the fibrin gel up to an applied strain of 12%. The second device, 
used for cell culture, consists of a motorized linear stage with a clamping 
mechanism that can hold up to two PDMS multi-well plates.  It can apply a 
large enough force to deform the PDMS to 10% strain in repeated cycles 
lasting for weeks, and if necessary can apply even greater strains.  The 
stage can also be left running in a standard cell culture incubator (100% 
humidity, 5% CO2, and temperature of 37 °C) during this time period, as it 
was during all experiments.  This platform has shown itself to be extremely 
robust, requiring minimal maintenance despite heavy use over the course 
of nearly 5 years. 
 Fulfillment of Specific Aim 2 required the use of the 3D cell culture 
platform to study the effects of cyclic strain on an in vitro model of 
angiogenesis.  This model consisted of a fibrin gel containing HUVECs 




excreted from smooth muscle cells cultured on the top of the fibrin gels, 
providing physical separation of the two cell types but still allowing cross-
talk via diffusion of soluble factors.  We successfully showed that cyclic 
strain did not negatively impact capillary network formation, an important 
observation due to the possibility of having to mechanically condition 
engineered tissues prior to implantation into patients.  We have also 
demonstrated that cyclic strain can be used to exert control over the 
direction of capillary formation during angiogenesis.  Capillaries cultured 
under cyclic strain in our system grow parallel to the direction of strain; if 
the strain is removed, they will begin growing in a random orientation even 
after the pre-establishment of an aligned network.  These findings provide a 
foundation for improved control over engineered tissue architecture that will 
be essential for developing large and complex organs in vitro. 
Attempts to ascertain a mechanism for the observed alignment ruled 
out causes based on ECM architecture.  Direct visualization of the fibrin 
matrix via confocal reflectance microscopy showed that fiber alignment was 
minimal, suggesting that the presence of a contact guidance cue generated 
by the applied strain was not responsible for the observed alignment.  
However, finite element modeling of the system presented the basis for a 




gradients in the fibrin matrix, which could in turn cause stiffness gradients 
in the matrix, and provide increased resistance to traction in the direction of 
applied strain.  The endothelial cells may be sensing these gradients and 
following the stiffer regions of the gel.  This hypothesis provided the basis 
for the study of a pathway known to regulate cell traction force in an effort 
to understand how the endothelial cells were biochemically responding to 
the strain and how this might affect their ability to respond by aligning the 
capillaries they formed. 
Fulfillment of Specific Aim 3 required the addition of several factors 
that influence a signaling pathway controlling cell traction force generation.  
The first were mutant genetic constructs of a small GTP-binding protein, 
RhoA, known to be influential in cytoskeletal rearrangement, cell 
polarization, and traction force generation.  HUVECs transduced with either 
the constitutively active or dominant negative forms of these genes 
displayed decreased network length compared to a vector control but still 
aligned parallel to applied strain.  This refuted the hypothesis that changes 
in the levels of active RhoA were mediating the alignment response and led 
to a broader analysis of a pathway involved in myosin-based traction force 
generation.  Three candidate proteins - ROCK, MLCK, and myosin ATPase 




inhibition of cell traction force generation would affect alignment.  In nearly 
all cases, pharmacologic inhibition of traction force caused the capillaries to 
be extremely short (HUVECs treated with ML7 displayed longer but widely 
variable network lengths) but had no effect on the HUVEC’s ability to align 
parallel to the applied strain.  Similarly, inhibition of myosin ATPase by 
BDM drastically shortened the total network length produced by the 
HUVECs and did not prevent the capillaries from aligning parallel to the 
applied strain.   
 
5.2 Future Directions 
  The observations made in this thesis opened up several avenues for 
additional research.  In addition, the experimental setup can be improved to 
increase throughput and make the device easier to use. 
We have shown that aligned capillary networks formed under cyclic 
strain will randomize their growth direction when strain is ceased and they 
are cultured statically, but it is unclear how they may respond to alternative 
strain regimens.  The observation that strain can align capillaries implies 
the possibility of finer control over capillary direction via the application of 
strain at different angles over the course of an experiment.  The simplest of 




application of strain in the direction perpendicular, ideally providing a stark 
contrast between the capillary networks before and after the change in 
strain direction.  Such experiments were not possible in the scope of this 
thesis due to the rectangular shape of the devices designed (the device 
was not wide enough to fit into the clamps if rotated 90°).  However, a 
simple re-design of the mold could make it fit in multiple configurations.  
Eventually this technique could be expanded to form more complex shapes 
by using multiple stretch directions in series. 
The reason for the use of a rectangular mold was throughput: two 
devices could be clamped onto each linear stage.  However, although each 
PDMS multi-well plate contained 4 wells, for a total of 8 on each linear 
stage, throughput was often an issue when various strain regimens were 
being tested because both devices in a given linear stage experience an 
identical strain regimen.  This problem will be compounded if wider devices 
are produced because only 1 will be able to fit into the stage.  There are 
several solutions to this problem.  First, shorter time points can be selected.  
Although it takes 3-4 days for bona fide capillaries to form, sprout direction 
can be determined in only 1-2 days and experiments with multiple strain 




widened to accommodate more devices, especially for experiments 
studying the effects of two or more different strain regimens in series. 
Another, less expected throughput limitation was the size and number 
of wells.  Because of the difficulty in distributing beads in such a small well, 
all four wells of each device were often used for a given condition.  This 
could be problematic if multiple cell types, drugs, or genetic manipulations 
are used in strain experiments.  The simplest fix for this would be to 
lengthen the devices.  The linear stage can easily accommodate devices of 
over twice the length of those used in these studies, potentially doubling or 
even tripling the number of wells.  Additionally, widening the clamp to 
accommodate more devices would alleviate this issue [1]. 
One of the biggest limitations of the experiments presented here is 
the exploration of only 2 strain regimens.  This was done for consistency 
and simplicity, but should be expanded on in future research.  Capillaries in 
vivo are generally shielded from the strong pulsatile flow experienced by 
larger vessels but do experience strains from neighboring cells during 
wound healing.  It would be interesting to test their response to a very low, 
continuous strain rate like they might experience as myofibroblasts contract 
a wound at the earliest stages of repair.  This could take the form of a low 




several days during capillary formation.   The latter of these would more 
closely simulate the gradual straining of tissue during wound healing and 
may lend insight into the wound revascularization process. 
From a tissue engineering perspective, control of pattern formation is 
critical, but it is unknown how different strain regimens than the two we 
have tested will affect capillary network alignment.  HUVECs whose 
traction force generating machinery was altered were remarkable in that 
their ability to align parallel to the strain was unperturbed.  However, 
alternative strain regimens may attenuate or enhance this response.  Both 
the frequency and amplitude of the strain can be modulated to test if the 
response is mediated by the magnitude of the strain or its rate.  Most likely, 
moderate values of amplitude and frequency will yield the greatest 
response and other regimens weaker responses, revealing a biphasic 
relationship.  In addition, the effects of strain rate and amplitude on network 
length are equally ambiguous.  The suggested experiments would allow an 
investigation of how these factors affect network length as well. 
We have also put forth the hypothesis that cyclic strain induces the 
fibrin matrix to locally stiffen surrounding a microcarrier bead, or possibly 
even the capillary tip itself, and present a stiffness gradient that the cells 




the system in question but validation of this model was not possible within 
the scope of this work.  It would require the measurement of individual fibrin 
fibers at various locations throughout the matrix using highly specialized 
equipment to build a map of matrix stiffness around a microcarrier bead or 
around a sprouting capillary.  Laser tweezers microrheology is the ideal 
method for such measurements because it can produce a micron-scale 
resolution map.  Building a stiffness map of the fibrin gel could elucidate 
differences in how the stiffness profile of the ECM is changed by invading 
capillaries exposed to strain as opposed to those that are not. 
The device presented here is capable of supporting many hydrogel 
formulations and cell types, and this work should be expanded using both.  
Endothelial progenitor cells are easily obtainable from adult blood and 
represent a clinically relevant cell type for future cell therapies [2].  
However, it must be determined if they respond similarly to strain as the 
HUVECs used in these studies.  Additionally, although aortic smooth 
muscle cells were used to support angiogenesis here, mesenchymal stem 
cells from bone marrow or isolated from blood represent the more likely 
clinical option, and thus their ability to support angiogenesis under cyclic 
strain must be investigated to validate their use in tissue engineering 




types may also be tested.  Cells in the lung undergo consistent cyclic 
stretch very similar to that tested here, and it would be advisable to test 
engineered lung tissue under cyclic strain in 3D using this device. 
Rather than leading to a dead end, the ability of capillary networks to 
align in the presence of traction force inhibition hints at the possibility of 
new mechanosensitive pathways that may be active during angiogenesis.  
Cadherin-mediated contacts are critically important for endothelial cells 
because of the continuous monolayer they create to line the interior of 
blood vessels.  These are known to mechanically couple the cells and may 
thus provide a means of communication between them [3].  VE-cadherin is 
also known to interact with fibrin directly [4-6] and could be a possible 
candidate for transducing mechanical forces to endothelial cells during 
angiogenesis.  Blocking antibodies could be used to impair this interaction 
by blocking the beta15-42 region of fibrin, rather than blocking the activity 
of VE-cadherin.  This would prevent circumvent the possibility of a blocking 
antibody disrupting the cell-cell contacts present in growing capillaries, 
ideally allowing angiogenesis to occur unabated.  Alternatively, 
recombinant fibrin could also be used to test this hypothesis.  Point 




from binding fibrin and thus block mechanotransduction through this 
pathway, again without significant disruption to angiogenesis. 
The final avenue that could be exploited to understand how HUVECs 
are responding to cyclic strain is by viewing them in real-time.  Building a 
microscope stage-mounted strain device and environmental chamber 
would allow for cell culture to be performed under cyclic strain with periodic, 
automated stoppage and imaging.  This method would greatly simplify the 
study of how changes in strain regimen affect the reaction of the capillary 
network.  In addition, drugs could be added to pre-formed networks and 
their changes could be monitored in a similar fashion.  It is still unclear 
whether capillaries that initially grew in a random orientation will align in the 
presence of strain, and real-time monitoring would be an ideal way to test 
this. 
We have demonstrated that angiogenic sprouting can be patterned 
via the application of cyclic strain and that this response is robust to 
perturbation by a host of pharmacologic and genetic manipulations.  A 
deeper understanding of the relationship between cells and the ECM will 
lay the foundation for the greater control of complex morphogenetic 




step toward the generation of vascularized engineered tissues and the 
development of implantable whole organs. 
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Appendix 1 : Production of PDMS Multi-well Plates 
Materials 
 Polydimethylsiloxane (PDMS) and cross-linker (Sylgard 184 kit) 
 Teflon mold 
 Binder clips 
 Surgical tubing (Tygon, ADF00001) 
 Polyester Film Tape (3M, UPC# 00021200393273) 
 Oven set to 60-70 °C 
 X-Acto knife 
 Forceps 
 Plastic knife 
 Plastic cup 
 Vacuum desiccator 
 Vacuum pump 
Protocol 
PDMS precursor preparation 
 Dispense PDMS into disposable plastic cup 
 Pour cross-linker into cup at 1 part crosslinker for 10 parts PDMS 
o You will need 16-18 g PDMS/cross-linker mixture to fill 1 mold 
 Stir PDMS and cross-linker using plastic knife until the mixture is 
white and completely opaque with tiny bubbles.  This ensures good 
mixing 
  Place PDMS-filled cup into vacuum desiccator and draw a vacuum 
o The bubbles in the mixture will expand and the volume will 
increase dramatically.  Be careful not to spill! 






 Clean any residual PDMS off of Teflon molds 
 Using the tape, cut tiny rectangles and place them on the top of the 
pillars in the bottom piece of the mold 
o THIS IS CRITICAL!  Without the tape the surface of the PDMS 
at these locations will not be transparent 
 Thread the surgical tubing through the holes in the bottom piece 
 Place the top and bottom pieces together and clamp them with the 
binder clips, leaving the input holes clear 
Pouring the molds 
 Pour PDMS carefully into one of the holes of the mold 
o You should be able to see the PDMS as it fills the mold by 
looking into the other hole 
 Once the mold is full, place it into the oven at 60 °C for at least 90 
minutes 
o Do not pour the mold so full that the PDMS makes contact with 
the top surface.  This will make the device prone to ripping 
during strain experiments and it will make the bottom opaque 
Removing the PDMS from the mold 
 Using the X-Acto knife, pry the two mold pieces apart 
 Remove the tubing from the mold and PDMS 
 Carefully pry the PDMS out of the mold 
 Examine the wells of the PDMS piece and remove any tape that is 
present 
 Replace the tape on the mold with fresh tape 
 The long holes in the PDMS should then be plugged with PDMS and 





Appendix 2 : Care and use of the linear stage 
 The linear stage is a product of Newmark Systems 
(www.newmarksystems.com) and uses a custom software package called 
“Quickmotion” to control it.  The device consists of three parts: the linear 
stage itself, the lid, and the controller.  The linear stage is connected to the 
controller via two cords that plug into the “motor” and “signals” ports on the 
stage.  They have corresponding ports on the controller.  The controller has 
additional ports: power, which connects the power cable, and the RS-232 
port, which connects to a computer.  I have attached the RS-232 port to 
another cable, an RS-232 to USB cable, so that computers without an RS-
232 port can access the controller. 
 Figure A-1 contains a picture of the software interface provided by 
Quickmotion.  It allows you to set the position of the clamp, set a “zero” 
position, and set positions relative to the zero.  The red circle next to the 
word “Connected” will turn green when the device is connected to a 
computer.  It is recommended to connect the device to your computer first, 
and then start the software.   Clicking on the “Virtual Joystick” box brings up 




commands into the controller and drive the device.  The “Record” function 
can also be used in conjunction with the standard interface to record 
motions that you input.  It can then play those back if a particular sequence 
of movements is desired.  The program also allows the user to save and 
load protocols for the stage to follow.  In the “Tools” menu, click “Program 
Editor” to bring up the editor dialogue, as shown in Figure A-3.  Attempts to 




a saved program click “Open” and select the program of interest.  It will be 
displayed in the box on the left, as in Figure A-4.  To program in a stretch 
protocol a particular sequence of buttons must be clicked, because I do not 
know how to do it any other way.  First, the “Virtual Joystick” dialogue must 
be open.  Then, click the “Record” button, then the “Stop” button.  This will 
activate the “Send” and “Run” buttons.  Copy the program of interest into 
the dialogue box as shown in figure A-5, then click “Send” and “Run.” The 
device should begin running the protocol. 
 The linear stage requires little maintenance, but some things are 




should be cleaned using a Dremel tool.  This is required about once every 
6 months.  The Dremel tool has a wire brush head that is ideal for this.  
Wear safety goggles and perform cleaning far from other people to protect 
them from debris.  Second, the lead screw in the stage requires greasing 
about once every 6 months.  If a grinding noise is noticed, this indicates 
that it should be greased.  Using the Allen wrenches in lab, take the device 
apart and apply the grease directly to the lead screw.  Run the stage back 
and forth over the entire length of the screw to fully lubricate it.  The 
grinding noise should disappear.  Reassemble the stage and it will be 























Programming a Strain Protocol 
 As shown in Figure 5, Quickmotion uses a unique programming 
language.  Some of the language is explained in the manual, so here I will 
explain the code as it relates to the stretch program that is shown in Figure 
5.  The code is as follows: 
1.  PGM 100 
2.  VM=6 
3.   LBL Start 
4.  MOVA -4 
5.  HOLD 2 
6.  MOVA 0 
7.  HOLD 2 
8.  BR Start 
9.  END 
10. PGM 
11. SAVE 
The first line defines the program number and is arbitrary.  The second line 
defines the maximum speed, in mm/s, that the linear stage will reach.  This 
is the most important determinant of the frequency.  Line 3 tells the 
controller to begin the program.  Line 4 dines the distance, in mm, that the 
stage will move on an absolute scale relative to the current zero position.  
Line 5 tells the stage to pause (not for 2 seconds).  The pause is very short.  
Line 6 tells the stage to move back to the zero position.  Line 7 again tells it 




program returns to the top and begins again).  Lines 9 and 10 tell the 
controller that there are no more movement commands and line 11 saves 
the program in the controller. 
 To my knowledge, you cannot set a frequency directly using the 
Quickmotion software.  To do so, you must measure the frequency based 
on the settings you provide and adjust accordingly.  This can be 
cumbersome but it is the only way to reliably set the frequency.  Relying on 
the “VM” value is not advised because the machine must accelerate, 
decelerate, pause, accelerate, and decelerate for a given cycle, and none 
of the accelerations are accounted for in the programming.  Thus, 





Appendix 3 : Performing the bead assay in a PDMS 
multi-well plate 
Materials 
 Coated beads (from previous protocol) 
 Sterile Serum-free EGM-2 
 Fully Supplemented EGM-2 
 0.05% trypsin 
 PBS 
 Bovine fibrinogen powder 
 Medium for your interstitial cells (PBL, SHED, SMC, NHLF, etc.) 
 10ml syringe 
 .22m syringe filter 
 FBS 
 Thrombin stock solution (50U/ml) 
 Microcentrifuge tubes 
 PDMS multi-well paltes 
 Linear stage  
 Sterile DDH2O 
 Sterile, untreated deep petri dishes  
 
Protocol 
 The day before, autoclave all of the PDMS multi-well plates 
 Warm all liquid reagents to 37°C 
 Weigh out enough fibrinogen to make as many gels as you need at 
2.5mg/ml final concentration 
 Place as many PDMS multi-well plates into deep petri dishes as 
required 
 Perform the rest of the protocol in a biosafety cabinet 
 Dissolve fibrinogen in warm, sterile, serum-free EGM-2 




 Ready 1 microcentrifuge tube for each well that you plan to fill (for 
each 0.5 ml gel) 
 Add sterile fibrinogen solution to each microcentrifuge tube 
o Add an amount pre-calculated to make a final concentration of 
2.5mg/ml after the addition of any other reagents 
 Remove coated beads from the incubator 
 Shear off the beads from the bottom of the flask using P-1000 
pipetter and leave flask in upright position 
o You will not get all of them, that is ok 
o This should only take 1-2 pipettes 
 Add number of beads you want to each microcentrifuge tube 
o The volume of bead suspension should be accounted for in 
your calculations of the final concentration 
 Add FBS to each microcentrifuge tube to make final FBS 
concentration 5% 
 Add 10l of thrombin stock solution into a microcentrifuge tube 
 Add the 63l cell suspension from 1 microcentrifuge tube into 1 well 
of the PDMS multi-well plate 
o A 63 l gel will make the height of the fibrin equal to the height 
in a 24-well plate 
o 1 500 l microcentrifuge tube will fill 7-8 wells of the PDMS 
plate 
 Repeat until you have made all of the gels you want 
 Allow the beads to settle to the bottom for 5 minutes 
 Incubate at 37°C for 25 minutes to allow the gels to finish 
polymerizing 




 If you are adding interstitial cells: 
 While the fibrin polymerizes, trypsinize the interstitial cells you want 
using your standard trypsiniziation protocol 
 Count cells 
 Once the incubation of the fibrin gel is complete, add 4,000 interstitial 
cells to the top of the fibrin gel 
 Add 100 l medium to feed 






 Once the interstitial cells are plated, place the PDMS plates into the 
incubator and prepare the linear stage 
 The basin in the linear stage should be filled with 50-70 ml sterile 
DDH2O to maintain humidity in the semi-open chamber 
o This will need to be replenished every 4-6 days  
 The clamps should be positioned such that they can grab enough 
PDMS surface without touching the liquid in the wells 
 The distance between the clamps should be measured with calipers 
so that strain can be applied accurately 
 Plug the device into the controller and the controller into a computer 
 Using the protocol in Appendix 2, program a strain protocol 
 Get the PDMS multi-well plate out of the incubator and clamp it in 
o Each linear stage has room for up to 2 PDMS plates 
 Begin the protocol and make sure that the clamps are holding 
 Place the lid on the device 
 Place the entire device, PLUGGED IN, into the incubator 





 The linear stage may generate enough heat to kill the cells in the 
PDMS plates if it is left on its default settings.  This will happen regardless 
of whether the basin underneath the PDMS plate is filled or empty.  The 
motor will become hot to the touch (not dangerously so, but uncomfortable 
to hold).  This heating does not appear to damage the motor.  If this occurs 
it means that the device is drawing more current than it should and it must 
be adjusted.  To adjust the current settings, open the “Terminal” dialogue 
under the “Tools” menu (Figure A-6).  In this dialogue enter the following 




1. MHC = 7 
2. MRC = 12 
3. MAC = 12 
4. SAVE 
This will tell the stage to draw significantly less current.  If the settings are 
too low the stage will visibly decrease in speed when it is under load (when 
devices are clamped in).  The default settings are MHC = 10, MRC = 20, 
MAC = 20.  After the settings are applied, if the linear stage is stopped for 
any reason they must be re-entered. 
 The stage must remain plugged into the controller for the duration of 
its use, but the controller does not need to be attached to a computer.  
Attaching the controller to a computer will not disrupt the protocol that the 









Appendix 4 : Creating a PDMS multi-well plate with a 
thin bottom 
 This protocol is for the creation of a PDMS multi-well plate with wells 
having bottoms thin enough to perform high magnification (60x and higher) 
microscopy on the hydrogel within.  It required the use of a spin coater 
(with David Lai’s recipe) and a plasma bonder to bond the thin PDMS to the 
bottom of the multi-well plate.  This protocol was performed using the 
Takayama lab’s, and David Lai’s personal equipment. 
Materials 
 PDMS multi-well plate 
 X-Acto knife 
 PDMS precursor 
 PDMS cross-linker 
 Disposable cup 
 Plastic knife (or any stirring utensil) 
 Spin Coater 
 Plasma bonder 
 Silane-coated glass 
 
Protocol 
 Using the X-Acto knife, carefully cut the bottoms of the wells out of 
the PDMS multi-well plate 
 Discard the extra pieces 
 Make PDMS as described above by mixing the components and de-




 Apply a small amount of PDMS to the silane-coated glass 
 Place the glass on the spin coater 
 Spin the PDMS to 100 m thickness using 
 Cure the PDMS at 120 °C for 2-5 minutes 
 Place the PDMS multi-well plate in a plasma bonder face down 
 Place the cured, thin PDMS (still on the glass) in the plasma bonder 
 Treat them for 1 minute 
 Very carefully, peel the thin PDMS off of the glass and place the 
treated side against the treated bottom of the PDMS multi-well plate 
o Be EXTREMELY careful to place the thin PDMS flat 
 Place the thin-bottomed PDMS in a petri dish for storage 
 
Once this protocol is complete the devices can be stored indefinitely just 
like normal multi-well plates.  They can also be autoclaved.  Keep in mind 
that the devices are now slightly deeper and may look different with gels in 
them.  This does not affect their performance.  Stretching them does not 
appear to damage the thin PDMS or cause it to delaminate from the multi-
well plate. 
 Performing high-magnification microscopy on these is identical to 
performing it in any other culture system; however, I have not used an oil 




Appendix 5 : Comparison of network length using 
various stromal and endothelial cell types 
A5.1 Introduction 
 While the above work has focused on a particular combination of 
endothelial and stromal cells, the bead assay has been used with many 
different stromal cell types [1, 2].  Understanding the pro-angiogenic 
characteristics of these cells is beneficial for choosing the proper 
supporting cells for tissue engineering applications and for finding more 
abundant, easier to access cell types for tissue engineering purposes. 
 Umbilical cords are a cheap and easily accessible source of 
endothelial cells, but not a likely candidate for tissue engineering purposes 
unless cord banking services become commonplace, and even in that case 
many people will not have a banked cord from which to draw these cells.  
Thus, alternative sources of endothelial cells must be found.  Human 
microvascular endothelial cells (HMVEC) can be extracted from dermal 
biopsies, making them an ideal candidate for the creation of autologous, 




robust.  Unfortunately, we show here that their ability to undergo 
angiogenesis is markedly reduced in the presence of multiple stromal cell 
types which are capable of supporting robust angiogenesis when cultured 
with HUVECs, however, because passage known is known by our lab to be 
an important factor in capillary network length (anecdotally), these results 
warrant additional study. 
A5.2 Methods 
A5.2.1 Cell culture 
 HUVECs were isolated from freshly harvested umbilical cords as 
previously described [2].  HMVECs (Lonza), SHEDs, and PDLSCs were 
acquired from the laboratory of Dr. Darnell Kaigler [3].  Both cell types were 
cultured in Endothelial Growth Medium-2 (EGM-2, Lonza, Walkersville, 
MD).  HUVECs were trypsinized and coated onto microcarrier beads at 
passage 2 and HMVECs at passage 6.  Primary HASMCs (Cascade 
Biologics, Portland, Oregon) were cultured in Medium 231 supplemented 
with Smooth Muscle Growth Supplement (SMGS, both Life Technologies), 
NHLFs were cultured in Medium 199 containing 10% serum (Life 
Technologies), MSCs were cultured in DMEM containing 10% serum (Life 
Technologies), and both SHEDs and PDLSCs were cultured in Alpha MEM 




antibiotics, and ascorbic acid 2 phosphate (see [3] for more detail).  
HASMCs were used before passage 15, NHLFs before passage 10, and 
both stem cell types at passage 6.  All cell culture was performed in a 37°C, 
5.0% CO2 incubator.  Media was changed every other day. 
A5.2.1 Creation of fibrin tissue co-cultures 
 To create fibrin tissues for 3D cell cultures, 490 l of 2.5 mg/ml 
bovine fibrinogen (lot# 029K7636V, Sigma-Aldrich) solutions containing 
approximately 100 HUVEC or HMVEC-coated microcarrier beads were 
combined with 10 l thrombin stock solution (50 U/ml, Sigma-Aldrich) and 
pipetted into 1 well of a 24-well culture plate.  All gels were left at room 
temperature for 5 minutes to allow the beads to settle to the bottom then 
incubated for 25 minutes in a 37°C, 5.0% CO2 incubator to allow gelation to 
complete.  After incubation, 25,000 HASMCs, NHLFs, SHEDs, or PDLSCs, 
depending on condition, were plated on top of each fibrin gel.  Tissues 
were cultured in a 37°C, 5.0% CO2 incubator for the duration of the 
experiments.  Media was changed every other day.  Cells were imaged at 
day 7 and total network length was quantified. 
A5.3 Results 








 HUVECs coated onto microcarrier beads and cultured in the 
presence of HASMCs, MSCs, SHEDs, and PDLSCs all generated capillary 
networks of equal length, supporting the hypothesis that all of these cell 
types support angiogenesis to an equal extent (Figure A-7). 
A5.3.2 Capillary network length depends on endothelial cell type 
 HUVECs and HMVECs cultured with various stromal cell types show 
a marked difference in total network length, independent of the stromal cell 
type (Figure A-8).  HUVECs cultured with NHLFs produce a network over 4 
times longer than HMVECs cultured with NHLFs, SHEDs, and PDLSCs.  
Qualitatively, the quality of the vessels produced by HMVECs appears to 
be similar to those produced by HUVECs, with the HMVEC capillaries also 
possessing lumen-like structures and clear, albeit shorter, vessels 
penetrating the matrix. 
 A5.4 Discussion 
 Here it is shown that three novel stromal cell types, HASMCs, SHEDs 
and PDLSCs, support angiogenesis to an extent equal to a mainstay 
stromal cell type used in our lab – MSCs.  This opens an avenue for 
angiogenesis research using an even wider variety of stromal cell types 
than before and provides a basis for comparison of new stromal cell types 








particular endothelial cell type used is important for the creation of large 
capillary networks and that HUVECs are an ideal endothelial cell source for 
this purpose. 
 Although it was shown that HUVECs out-perform HMVECs at 
producing large capillary networks, it should be noted that unpublished 
evidence from our laboratory has shown that the passage number of the 
endothelial cells is an important factor when considering network length 
and that higher passage HUVECs produce dramatically shorter networks.  
It is unknown whether the effect of endothelial cell type in this study is due 
solely to differences between HUVECs and HMVECs or due to the use of 
passage 6 HMVECs.  Future research is necessary to parse out whether 
these effects are due to cell type, passage number, or if both have an effect 
on network length.  Stromal cell passage number is not known to affect 
network length in our hands.  NHLFs have been used up to passage 10 [4] 
and HASMCs have been used up to passage 15 [5] with no noticeable 
changes in network length.  The effect of passage number on the 
effectiveness of SHEDs, PDLSCs, and other stromal cell types remains to 
be determined. 
 The hypothesis that the extent of angiogenesis is dependent on 




shows that each of the HMVEC conditions produced network length of 
equal extent, despite being much shorter than those produced by HUVECs.  
This implies a need for careful choice of endothelial as well as stromal cell 
types when designing an engineered tissue construct and that there are 
likely optimal choices of both cell types for particular tissue engineering 
applications.  Future studies should examine the differences between 
various combinations of endothelial and stromal cells to determine if there 
are any synergistic or antagonistic interaction effects. 
 Finally, all of these experiments were carried out in fibrin matrices 
and the behavior of all of the cell types used in other ECM materials is not 
yet known.  Particular ECMs may be more conducive to angiogenesis by 
certain endothelial cell types than others, and thus optimization of the ECM 
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